Manulife Private Credit Fund 10-Q 2024 Q3 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

     

to

     

Commission File Number

814-01664

MANULIFE PRIVATE CREDIT FUND

(Exact name of registrant as specified in its charter)

Delaware	92-3968552
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

197 Clarendon Street, Boston, Massachusetts 02116

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (617)

663-3000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
None	None	None

Securities registered pursuant to Section 12(g) of the Act:

Class NAV Common Shares of Beneficial Interest, par value $0.01 per share

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☐
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). Yes ☐ No ☒

As of September 30, 2024, there was no established public market for the Registrant’s common shares of beneficial interest (“Common Shares”). The number of the Registrant’s Common Shares, $0.01 par value per share, outstanding as of November 12, 2024, was 5,360,173.

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION		1
ITEM 1. Consolidated Financial Statements (Unaudited)		1
Consolidated Schedule of Investments as of September 30, 2024 (Unaudited) and Schedule of Investment as of December 31, 2023		1
Consolidated Statements of Assets and Liabilities as of September 30, 2024 (Unaudited) and December 31, 2023		12
Consolidated Statements of Operations for the three and nine months ended September 30, 2024 (Unaudited)		13
Consolidated Statements of Changes in Net Assets for the three and nine months ended September 30, 2024 (Unaudited)		14
Consolidated Statement of Cash Flows for the nine months ended September 30, 2024 (Unaudited)		15
Notes to Consolidated Financial Statements (Unaudited)		16
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		28
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk		38
ITEM 4. Controls and Procedures		39
PART II. OTHER INFORMATION		39
ITEM 1. Legal Proceedings		39
ITEM 1A. Risk Factors		39
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds		39
ITEM 3. Defaults Upon Senior Securities		39
ITEM 4. Mine Safety Disclosures		39
ITEM 5. Other Information		40
ITEM 6. Exhibits		41
SIGNATURES		42

PART I. FINANCIAL INFORMATION

ITEM 1. Consolidated Financial Statements (Unaudited)

Manulife Private Credit Fund

Consolidated Schedule of Investments

9-30-24

(Unaudited)

	Rate (%)		Maturity date		Par value^		Value
Non-controlled/Non-affiliated
Senior loans (A)(B) 135.5% (Cost $151,795,958)							$	153,370,661
Consumer discretionary 24.9%								28,192,634
Automobile components 1.9%
Paint Intermediate III LLC, Revolver (3 month CME Term SOFR + 5.500% and Prime rate + 4.500%) (C)		10.949		10-07-27		216,516		216,516
Paint Intermediate III LLC, Term Loan (3 month CME Term SOFR + 5.500%) (D)		10.852		10-06-28		1,933,880		1,933,880
Diversified consumer services 6.5%
Capital Construction LLC, Add-On Delayed Draw Term Loan (1 month CME Term SOFR + 5.500%) (C)		10.801		10-22-26		499,260		503,005
Capital Construction LLC, Add-On Term Loan (1 month CME Term SOFR + 5.500%)		10.801		10-22-26		327,372		329,827
Capital Construction LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 5.500%) (D)		10.801		10-22-26		1,136,650		1,145,174
Capital Construction LLC, Revolver (C)		—		10-22-26		508,039		508,039
Capital Construction LLC, Term Loan (1 month CME Term SOFR + 5.500%) (D)		10.801		10-22-26		838,524		844,813
Leap Service Partners LLC, Delayed Draw Term Loan (1 and 3 month CME Term SOFR + 5.000%) (C)		9.956		03-15-29		1,756,235		1,756,235
Leap Service Partners LLC, Revolver (1 and 3 month CME Term SOFR + 5.000%) (C)		10.096		03-15-29		588,235		588,235
Leap Service Partners LLC, Term Loan (1 month CME Term SOFR + 5.000%)		10.083		03-15-29		1,638,824		1,638,824
Hotels, restaurants and leisure 7.4%
Bandon Fitness, Inc., 4th Amendment Delayed Draw Term Loan (C)		—		07-27-28		1,705,489		1,705,489
Bandon Fitness, Inc., Delayed Draw Term Loan (3 month CME Term SOFR + 6.000%) (C)		11.302		07-27-28		568,589		568,589
Bandon Fitness, Inc., Revolver (C)		—		07-27-28		114,804		114,804
Bandon Fitness, Inc., Term Loan (3 month CME Term SOFR + 6.000%) (D)		11.402		07-27-28		1,468,227		1,468,227
Star Logistics & Hospitality Services LLC, Delayed Draw Term Loan (C)		—		06-18-29		1,607,143		1,607,143
Star Logistics & Hospitality Services LLC, Revolver (3 month CME Term SOFR + 4.750%) (C)		9.613		06-18-29		535,714		535,714
Star Logistics & Hospitality Services LLC, Term Loan (3 month CME Term SOFR + 4.750%)		9.613		06-18-29		2,351,250		2,351,250
Leisure products 3.5%
4M Capital, Ltd., Revolver (C)		—		06-18-27		528,000		524,040
4M Capital, Ltd., Term Loan (3 month CME Term SOFR + 5.000%) (D)		9.604		06-18-27		3,454,640		3,428,730
Specialty retail 3.9%
RPC TopCo, Inc., Revolver (C)		—		09-02-31		545,455		537,273
RPC TopCo, Inc., Term Loan (6 month CME Term SOFR + 5.000%)		9.245		09-02-31		3,954,545		3,895,227

See Notes to consolidated financial statements

1

Manulife Private Credit Fund

Consolidated Schedule of Investments 9-30-24 (Unaudited)

	Rate (%)		Maturity date		Par value^		Value
Consumer discretionary (continued)
Textiles, apparel and luxury goods 1.7%
CPC Lakeshirts Acquisition LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 5.250%)		10.764		09-02-27		216,336	$	214,714
CPC Lakeshirts Acquisition LLC, Revolver (1 month CME Term SOFR + 5.250%) (C)		10.220		09-02-27		380,027		377,177
CPC Lakeshirts Acquisition LLC, Term Loan (1 month CME Term SOFR + 5.250%) (D)		10.764		09-04-28		1,410,287		1,399,709
Consumer staples 6.6%								7,416,380
Consumer staples distribution and retail 6.6%
Hill Country Dairies, Inc., Delayed Draw Term Loan (C)		—		08-01-30		1,088,710		1,072,379
Hill Country Dairies, Inc., Revolver (6 month CME Term SOFR + 4.750%) (C)		8.995		08-01-30		725,806		714,919
Hill Country Dairies, Inc., Term Loan (3 month CME Term SOFR + 4.750%)		9.998		08-01-30		2,685,484		2,645,202
PAK Quality Foods Acquisition LLC, Delayed Draw Term Loan (C)		—		12-28-29		537,313		537,313
PAK Quality Foods Acquisition LLC, Revolver (C)		—		12-28-29		313,433		313,433
PAK Quality Foods Acquisition LLC, Term Loan (1 month CME Term SOFR + 6.000%) (D)		10.955		12-28-29		2,133,134		2,133,134
Financials 1.9%								2,158,884
Capital markets 1.9%
Steward Partners Global Advisory LLC, Delayed Draw Term Loan (6 month CME Term SOFR + 5.500%) (C)		10.553		10-13-28		930,722		930,722
Steward Partners Global Advisory LLC, Revolver (C)		—		10-13-28		311,716		311,716
Steward Partners Global Advisory LLC, Term Loan (3 and 6 month CME Term SOFR + 5.500%) (D)		10.254		10-13-28		916,446		916,446
Health care 26.5%								29,996,181
Health care equipment and supplies 3.3%
CPC/Cirtec Holdings, Inc., Add-On Term Loan (1 month CME Term SOFR + 5.000%)		9.845		01-30-29		1,602,015		1,602,015
CPC/Cirtec Holdings, Inc., Term Loan (1 month CME Term SOFR + 5.000%) (D)		9.845		01-30-29		2,147,744		2,147,744
Health care providers and services 23.2%
In Vitro Sciences LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 6.000%) (C)		10.960		02-28-29		707,591		681,056
In Vitro Sciences LLC, Revolver (C)		—		02-28-29		177,778		171,111
In Vitro Sciences LLC, Term Loan (1 month CME Term SOFR + 6.000%) (D)		10.960		02-28-29		3,095,556		2,979,472
Midwest Eye Services LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 4.500%) (D)		9.445		08-20-27		1,243,500		1,243,500
Midwest Eye Services LLC, Revolver (C)		—		08-20-27		142,385		142,385
Midwest Eye Services LLC, Term Loan (1 month CME Term SOFR + 4.500%) (D)		9.445		08-20-27		738,841		738,841
OIS Management Services LLC, Add-On Delayed Draw Term Loan (3 month CME Term SOFR + 4.750%) (C)		9.354		11-16-28		2,344,227		2,332,506
OIS Management Services LLC, Delayed Draw Term Loan (3 month CME Term SOFR + 4.750%) (D)		9.354		11-16-28		552,149		549,389
OIS Management Services LLC, Revolver (C)		—		11-16-28		167,626		166,788
OIS Management Services LLC, Term Loan (3 month CME Term SOFR + 4.750%) (D)		9.354		11-16-28		1,430,969		1,423,814

See Notes to consolidated financial statements

2

Manulife Private Credit Fund

Consolidated Schedule of Investments 9-30-24 (Unaudited)

	Rate (%)		Maturity date		Par value^		Value
Health care (continued)
Health care providers and services (continued)
Pediatric Home Respiratory Services LLC, Delayed Draw Term Loan (6 month CME Term SOFR + 5.750% and Prime rate + 5.250%) (D)		11.131		12-04-25		1,155,179	$	1,155,179
Pediatric Home Respiratory Services LLC, Incremental Delayed Draw Term Loan (6 month CME Term SOFR + 6.250% and Prime rate + 5.250%) (D)		11.790		12-04-25		994,510		994,510
Pediatric Home Respiratory Services LLC, Term Loan (6 month CME Term SOFR + 6.250%)		11.361		12-04-25		1,824,742		1,824,742
Refocus Management Services LLC, Delayed Draw Term Loan (3 month CME Term SOFR + 6.000%) (C)		11.204		02-14-29		1,050,000		1,034,250
Refocus Management Services LLC, Revolver (C)		—		02-14-29		210,526		207,368
Refocus Management Services LLC, Term Loan (3 month CME Term SOFR + 6.000%) (D)		11.401		02-14-29		2,723,158		2,682,311
The Smilist DSO LLC, Delayed Draw Term Loan 2024-1 (3 month CME Term SOFR + 6.000%)		10.666		04-04-29		700,214		694,962
The Smilist DSO LLC, Delayed Draw Term Loan 2024-2 (3 month CME Term SOFR + 6.000%) (C)		11.066		04-04-29		561,404		557,193
The Smilist DSO LLC, Revolver (C)		—		04-04-29		140,351		139,298
The Smilist DSO LLC, Term Loan (3 month CME Term SOFR + 6.000%)		10.604		04-04-29		2,590,000		2,570,575
VPD Management, Inc., Delayed Draw Term Loan (C)		—		11-02-26		3,028,571		2,998,286
VPD Management, Inc., Revolver (C)		—		11-02-26		228,571		226,286
VPD Management, Inc., Term Loan (3 month CME Term SOFR + 6.000%)		10.604		11-02-26		740,000		732,600
Industrials 64.0%								72,415,821
Air freight and logistics 3.9%
PNB Holdings III LLC, Delayed Draw Term Loan (C)		—		09-17-30		1,227,273		1,208,864
PNB Holdings III LLC, Revolver (1 month CME Term SOFR + 4.500%) (C)		9.583		09-17-30		818,182		805,909
PNB Holdings III LLC, Term Loan (1 month CME Term SOFR + 4.500%)		9.583		09-17-30		2,454,545		2,417,727
Building products 2.9%
Lockmasters Security Intermediate, Inc., Delayed Draw Term Loan (C)		—		09-01-27		878,274		871,687
Lockmasters Security Intermediate, Inc., Revolver (C)		—		09-01-27		205,895		204,350
Lockmasters Security Intermediate, Inc., Term Loan (3 month CME Term SOFR + 5.500%) (D)		10.365		09-01-27		2,157,044		2,140,866
Commercial services and supplies 26.0%
Air Buyer, Inc., Delayed Draw Term Loan (C)		—		07-23-30		750,000		736,875
Air Buyer, Inc., Revolver (C)		—		07-23-30		340,909		334,943
Air Buyer, Inc., Term Loan (3 month CME Term SOFR + 5.250%)		10.533		07-23-30		3,409,091		3,349,432
American Combustion Industries, Inc., Delayed Draw Term Loan A (1 month CME Term SOFR + 5.000%) (C)		9.945		08-31-28		814,114		801,903
American Combustion Industries, Inc., Delayed Draw Term Loan B (C)		—		08-31-28		957,781		943,415
American Combustion Industries, Inc., Revolver (C)		—		08-31-28		359,168		353,781
American Combustion Industries, Inc., Term Loan (1 month CME Term SOFR + 5.000%)		9.945		08-31-28		2,368,936		2,333,402

See Notes to consolidated financial statements

3

Manulife Private Credit Fund

Consolidated Schedule of Investments 9-30-24 (Unaudited)

	Rate (%)		Maturity date		Par value^		Value
Industrials (continued)
Commercial services and supplies (continued)
BCTS Parent LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 5.000%) (C)		9.845		12-26-29		974,832	$	974,832
BCTS Parent LLC, Revolver (1 month CME Term SOFR + 5.000%) (C)		10.281		12-26-29		354,484		354,484
BCTS Parent LLC, Term Loan (3 month CME Term SOFR + 5.000%) (D)		10.252		12-26-29		1,407,302		1,407,302
Beary Landscaping LLC, Delayed Draw Term Loan (C)		—		12-21-29		422,535		413,028
Beary Landscaping LLC, Revolver (Prime rate + 4.750%) (C)		12.750		12-21-29		422,535		413,028
Beary Landscaping LLC, Term Loan (1 month CME Term SOFR + 5.750%) (D)		10.595		12-21-29		2,138,768		2,090,645
Diverzify Intermediate LLC, Delayed Draw Term Loan (C)		—		05-11-27		1,371,429		1,350,857
Diverzify Intermediate LLC, Term Loan (3 month CME Term SOFR + 5.750%)		11.068		05-11-27		2,628,571		2,490,572
Renovation Systems LLC, Add-On Delayed Draw Term Loan (C)		—		01-24-28		1,096,996		1,096,996
Renovation Systems LLC, Add-On Term Loan (3 month CME Term SOFR + 6.250%)		11.093		01-24-28		1,094,237		1,094,237
Renovation Systems LLC, Delayed Draw Term Loan (3 month CME Term SOFR + 6.250%)		11.666		01-24-28		251,158		251,158
Renovation Systems LLC, Revolver (3 month CME Term SOFR + 6.250%) (C)		11.652		01-24-28		125,263		125,263
Renovation Systems LLC, Term Loan (3 month CME Term SOFR + 6.250%) (D)		11.093		01-24-28		1,924,420		1,924,420
Security Services Acquisition Sub Corp., 11th Amendment Term Loan A (1 month CME Term SOFR + 5.750%)		10.695		09-30-27		1,816,000		1,816,000
Security Services Acquisition Sub Corp., 12th Amendment Term Loan A (1 month CME Term SOFR + 5.750%)		10.695		09-30-27		507,499		507,499
Security Services Acquisition Sub Corp., 7th Amendment Delayed Draw Term Loan (1 month CME Term SOFR + 5.750%) (D)		10.695		09-30-27		188,415		188,415
Security Services Acquisition Sub Corp., 8th Amendment Delayed Draw Term Loan (1 month CME Term SOFR + 5.750%) (D)		10.695		09-30-27		1,236,214		1,236,214
Security Services Acquisition Sub Corp., Term Loan (1 month CME Term SOFR + 5.750%) (D)		10.695		09-30-27		729,316		729,316
XpressMyself.com LLC, Incremental Term Loan (3 month CME Term SOFR + 5.750%) (D)		10.776		09-07-28		592,894		589,930
XpressMyself.com LLC, Revolver (C)		—		09-07-28		233,050		230,137
XpressMyself.com LLC, Term Loan (3 month CME Term SOFR + 5.500%) (D)		10.546		09-07-28		1,324,655		1,308,097
Professional services 7.7%
Health Management Associates, Inc., Delayed Draw Term Loan (3 month CME Term SOFR + 6.250%) (C)		11.215		03-30-29		307,593		307,593
Health Management Associates, Inc., Revolver (Prime rate + 5.250%) (C)		13.250		03-30-29		124,004		124,004
Health Management Associates, Inc., Term Loan (3 month CME Term SOFR + 6.250%) (D)		11.366		03-30-29		1,698,569		1,698,569
Library Associates LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 6.250%) (D)		11.499		03-01-27		290,164		290,164
Library Associates LLC, Revolver (1 month CME Term SOFR + 6.250%) (C)		11.240		02-26-27		72,418		72,418
Library Associates LLC, Term Loan (1 month CME Term SOFR + 6.250%) (D)		11.265		02-26-27		1,786,184		1,786,184

See Notes to consolidated financial statements

4

Manulife Private Credit Fund

Consolidated Schedule of Investments 9-30-24 (Unaudited)

	Rate (%)		Maturity date		Par value^		Value
Industrials (continued)
Professional services (continued)
WeLocalize, Inc., Delayed Draw Term Loan (3 month CME Term SOFR + 5.250%)		9.954		06-23-26		513,780	$	507,358
WeLocalize, Inc., Incremental Term Loan (3 month CME Term SOFR + 5.250%)		9.954		06-23-26		2,024,273		1,998,970
WeLocalize, Inc., Revolver (1 month CME Term SOFR + 5.250%) (C)		10.273		06-23-26		421,597		416,327
WeLocalize, Inc., Term Loan (3 month CME Term SOFR + 5.250%)		9.954		06-23-26		1,540,349		1,521,095
Trading companies and distributors 23.5%
BLP Buyer, Inc., Add-On Term Loan (1 month CME Term SOFR + 5.750%)		10.595		12-24-29		919,355		917,056
BLP Buyer, Inc., Delayed Draw Term Loan (1 month CME Term SOFR + 5.750%)		10.595		12-24-29		290,323		289,597
BLP Buyer, Inc., Revolver (1 month CME Term SOFR + 5.750%) (C)		10.595		12-24-29		290,323		289,597
BLP Buyer, Inc., Term Loan (1 month CME Term SOFR + 5.750%) (D)		10.595		12-24-29		2,413,306		2,407,273
Genuine Cable Group LLC, Term Loan (1 month CME Term SOFR + 5.750%) (D)		10.695		11-01-26		2,147,607		2,083,179
Krayden Holdings, Inc., Add-On Delayed Draw Term Loan (C)		—		03-01-29		875,683		875,683
Krayden Holdings, Inc., Add-On Revolver (C)		—		03-01-29		301,960		301,960
Krayden Holdings, Inc., Add-On Term Loan (1 month CME Term SOFR + 4.750%)		9.595		03-01-29		875,683		875,683
Krayden Holdings, Inc., Delayed Draw Term Loan A (C)		—		03-01-29		258,694		258,694
Krayden Holdings, Inc., Delayed Draw Term Loan B (C)		—		03-01-29		258,694		258,694
Krayden Holdings, Inc., Revolver (C)		—		03-01-29		272,309		272,309
Krayden Holdings, Inc., Term Loan (1 month CME Term SOFR + 4.750%) (D)		9.595		03-01-29		1,367,944		1,367,944
M&D Midco, Inc., 1st Amendment Delayed Draw Term Loan (1 and 3 month CME Term SOFR + 5.750%) (C)		10.787		08-31-28		854,465		845,920
M&D Midco, Inc., Delayed Draw Term Loan (3 month CME Term SOFR + 6.000%)		11.298		08-31-28		496,283		495,043
M&D Midco, Inc., Revolver (3 month CME Term SOFR + 6.000%) (C)		11.383		08-31-28		250,675		250,048
M&D Midco, Inc., Term Loan (3 month CME Term SOFR + 6.000%) (D)		11.207		08-31-28		1,405,183		1,401,670
PVI Holdings, Inc., Term Loan (3 month CME Term SOFR + 6.390%) (D)		11.773		01-18-28		2,147,607		2,147,607
SurfacePrep Buyer LLC, Delayed Draw Term Loan (C)		—		02-04-30		547,945		549,315
SurfacePrep Buyer LLC, Revolver (1 month CME Term SOFR + 5.000%) (C)		10.195		02-04-30		547,945		547,945
SurfacePrep Buyer LLC, Term Loan (3 month CME Term SOFR + 5.000%) (D)		10.241		02-04-30		2,896,849		2,904,091
WWEC Holdings III Corp., Delayed Draw Term Loan (3 month CME Term SOFR + 5.750%) (D)		10.354		10-03-28		337,021		337,021
WWEC Holdings III Corp., Incremental Delayed Draw Term Loan (3 month CME Term SOFR + 5.750%) (C)		10.354		10-03-28		973,075		973,075
WWEC Holdings III Corp., Revolver (C)		—		10-03-28		434,020		434,020

See Notes to consolidated financial statements

5

Manulife Private Credit Fund

Consolidated Schedule of Investments 9-30-24 (Unaudited)

	Rate (%)		Maturity date			Par value^		Value
Industrials (continued)
Trading companies and distributors (continued)
WWEC Holdings III Corp., Term Loan (3 month CME Term SOFR + 5.750%) (D)		10.354		10-03-28			1,544,083	$	1,544,083
Xenon Arc, Inc, Term Loan (3 month CME Term SOFR + 5.250%)		10.629		12-20-28			3,990,000		3,970,048
Information technology 7.7%									8,744,151
IT services 4.6%
AIDC IntermediateCo LLC, Term Loan (3 month CME Term SOFR + 5.100%) (D)		10.533		07-22-27			2,147,676		2,147,676
Jetson Buyer, Inc., Revolver (Prime rate + 4.500%) (C)		12.500		04-09-30			443,656		441,437
Jetson Buyer, Inc., Term Loan (1 month CME Term SOFR + 5.500%)		10.345		04-09-30			2,611,025		2,597,970
Software 3.1%
Alta Buyer LLC, Add-On Term Loan (3 month CME Term SOFR + 5.000%) (D)		9.604		12-21-27			2,147,607		2,142,238
Alta Buyer LLC, Term Loan (3 month CME Term SOFR + 5.000%)		9.604		12-21-27			1,418,376		1,414,830
Materials 3.9%									4,446,610
Chemicals 3.9%
Chemtron Supply LLC, Add-On Delayed Draw Term Loan (C)		—		03-02-29			2,333,630		2,310,294
Chemtron Supply LLC, Delayed Draw Term Loan (3 month CME Term SOFR + 4.750%)		9.522		03-02-29			723,237		716,004
Chemtron Supply LLC, Revolver (C)		—		03-02-29			362,979		359,350
Chemtron Supply LLC, Term Loan (3 month CME Term SOFR + 4.750%) (D)		9.354		03-02-29			1,071,679		1,060,962
			Yield (%)			Shares		Value
Short-term investments 10.4% (Cost $11,836,858)								$	11,836,858
Short-term funds 10.4%									11,836,858
Dreyfus Treasury Obligations Cash Management Fund, Institutional Class				5.0100	(E)		11,836,858		11,836,858
Total investments (Cost $163,632,816) 145.9%								$	165,207,519
Less unfunded loan commitments (32.4%)									(36,716,731	)
Net investments (Cost $126,916,085) 113.5%								$	128,490,788
Other assets and liabilities, net (13.5%)									(15,278,707	)
Total net assets 100.0%								$	113,212,081

The percentage shown for each investment category is the total value of the category as a percentage of the net assets of the Fund.

^ All par values are denominated in U.S. dollars unless otherwise indicated.

See Notes to consolidated financial statements

6

Manulife Private Credit Fund

Consolidated Schedule of Investments 9-30-24 (Unaudited)

Security Abbreviations and Legend
CME	CME Group Published Rates
SOFR	Secured Overnight Financing Rate
(A)	Securities are valued using significant unobservable inputs and are classified as Level 3 in the fair value hierarchy. Refer to Note 2 to the consolidated financial statements.
(B)	Senior loans are variable rate obligations which generally pay interest rates that are periodically redetermined by reference to a base lending rate and spread, which are both subject to change. The rate shown represents the rate at period end.
(C)	Unfunded or partially unfunded loan commitments. The stated interest rate reflects the reference rate and spread of the funded portion, if any. No interest rate is determined for unfunded positions. See Note 2 for more information.
(D)	All or a portion of this security is pledged as collateral pursuant to the JPM Funding Facility.
(E)	The rate shown is the annualized seven-day yield as of 9-30-24.

At

9-30-24,

the aggregate cost of investments for federal income tax purposes was $126,471,722. Net unrealized appreciation aggregated to $2,019,066, of which $2,259,406 related to gross unrealized appreciation and $240,340 related to gross unrealized depreciation.

See Notes to consolidated financial statements

7

Manulife Private Credit Fund

Schedule of Investments

12-31-23

	Rate (%)		Maturity date		Par value^		Value
Non-controlled/Non-affiliated
Senior loans (A)(B) 87.9% (Cost $57,833,046)							$	58,427,889
Consumer discretionary 9.5%								6,308,073
Bandon Fitness, Inc., Delayed Draw Term Loan (3 month CME Term SOFR + 6.000%) (C)		11.516		07-27-28		571,677		564,531
Bandon Fitness, Inc., Revolver (3 month CME Term SOFR + 6.000%) (C)		11.534		07-27-28		114,804		113,369
Bandon Fitness, Inc., Term Loan (3 month CME Term SOFR + 6.000%)		11.533		07-27-28		1,479,463		1,460,970
CPC Lakeshirts Acquisition LLC, Delayed Draw Term Loan (3 month CME Term SOFR + 5.500%) (C)		11.145		09-02-27		316,398		294,250
CPC Lakeshirts Acquisition LLC, Revolver (3 month CME Term SOFR + 5.500%) (C)		11.145		09-02-27		380,027		353,425
CPC Lakeshirts Acquisition LLC, Term Loan (3 month CME Term SOFR + 5.500%)		11.145		09-04-28		1,470,836		1,367,877
Library Associates LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 6.250%)		11.692		03-01-27		292,374		290,912
Library Associates LLC, Revolver (C)		—		02-28-27		72,418		72,056
Library Associates LLC, Term Loan (1 month CME Term SOFR + 6.250%)		11.709		02-26-27		1,799,681		1,790,683
Consumer staples 4.5%								2,966,865
Pak Quality Foods Acquisition LLC, Delayed Draw Term Loan (C)		—		12-28-29		537,313		531,940
Pak Quality Foods Acquisition LLC, Revolver (3 month CME Term SOFR + 6.250%) (C)		11.858		12-28-29		313,433		307,164
Pak Quality Foods Acquisition LLC, Term Loan (3 month CME Term SOFR + 6.250%)		11.858		12-28-29		2,149,254		2,127,761
Financials 3.2%								2,142,426
Steward Partners Global Advisory LLC, Delayed Draw Term Loan (6 month CME Term SOFR + 5.250%) (C)		10.822		10-14-28		934,369		922,690
Steward Partners Global Advisory LLC, Revolver (C)		—		10-14-28		311,716		307,820
Steward Partners Global Advisory LLC, Term Loan (6 month CME Term SOFR + 5.250%)		10.893		10-14-28		923,459		911,916
Health care 12.7%								8,455,491
CPC/Cirtec Holdings, Inc., Term Loan (3 month CME Term SOFR + 6.250%)		11.598		01-30-29		2,164,098		2,120,816
Health Management Associates, Inc., Delayed Draw Term Loan (3 month CME Term SOFR + 6.250%) (C)		11.727		03-30-29		308,090		305,779
Health Management Associates, Inc., Revolver (C)		—		03-30-29		124,004		123,074
Health Management Associates, Inc., Term Loan (3 month CME Term SOFR + 6.250%)		11.727		03-30-29		1,707,294		1,694,490
Midwest Eye Services LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 4.500%)		9.956		08-20-27		1,252,965		1,215,376
Midwest Eye Services LLC, Revolver (C)		—		08-20-27		142,385		138,113
Midwest Eye Services LLC, Term Loan (3 month CME Term SOFR + 4.500%)		10.038		08-20-27		744,540		722,204
Pediatric Home Respiratory Services LLC, Delayed Draw Term Loan (Prime rate + 5.250% and 1 month CME Term SOFR + 6.250%)		12.024		12-04-25		1,166,938		1,143,600
Pediatric Home Respiratory Services LLC, Incremental Delayed Draw Term Loan (Prime rate + 5.250% and 1 month CME Term SOFR + 6.250%)		12.265		12-04-25		1,004,596		992,039

See Notes to consolidated financial statements

8

Manulife Private Credit Fund

Schedule of Investments 12-31-23

	Rate (%)		Maturity date		Par value^		Value
Industrials 48.3%								32,102,459
AIDC Intermediate LLC, Term Loan (3 month CME Term SOFR + 6.250%)		11.798		07-22-27		2,164,070		2,142,430
BCTS Parent LLC, Delayed Draw Term Loan (C)		—		12-26-29		974,832		974,832
BCTS Parent LLC, Revolver (1 month CME Term SOFR + 5.250%) (C)		10.606		12-26-29		354,484		350,939
BCTS Parent LLC, Term Loan (1 month CME Term SOFR + 5.250%)		10.606		12-26-29		1,417,937		1,403,758
Beary Landscaping LLC, Delayed Draw Term Loan (C)		—		12-21-29		422,535		414,085
Beary Landscaping LLC, Revolver (C)		—		12-21-29		422,535		414,085
Beary Landscaping LLC, Term Loan (1 month CME Term SOFR + 5.750%)		11.107		12-21-29		1,901,408		1,863,380
BLP Buyer, Inc., Delayed Draw Term Loan (C)		—		12-21-29		290,323		284,516
BLP Buyer, Inc., Revolver (1 month CME Term SOFR + 5.750%) (C)		11.107		12-21-29		290,323		284,516
BLP Buyer, Inc., Term Loan (1 month CME Term SOFR + 5.750%)		11.107		12-21-29		2,419,355		2,370,965
Capital Construction LLC, Delayed Draw Term Loan (1 month CME Term SOFR + 6.250%)		11.695		10-22-26		1,145,261		1,148,124
Capital Construction LLC, Revolver (1 month CME Term SOFR + 6.250%) (C)		11.693		10-22-26		179,846		179,846
Capital Construction LLC, Term Loan (1 month CME Term SOFR + 6.250%)		11.693		10-22-26		844,887		847,000
Gannet Fleming, Inc., Revolver (C)		—		12-20-28		297,877		297,877
Gannet Fleming, Inc., Term Loan (3 month CME Term SOFR + 6.500%)		11.948		12-20-28		1,867,690		1,881,698
Genuine Cable Group LLC, Term Loan (1 month CME Term SOFR + 5.500%)		10.956		11-01-26		2,164,043		2,104,532
M+D Midco, Inc., Delayed Draw Term Loan (3 month CME Term SOFR + 5.500%) (C)		11.032		08-31-28		500,044		500,044
M+D Midco, Inc., Revolver (Prime rate + 4.500%) (C)		13.000		08-31-28		250,675		250,675
M+D Midco, Inc., Term Loan (3 month CME Term SOFR + 5.500%)		11.038		08-31-28		1,415,937		1,415,937
OIS Management Services LLC, Delayed Draw Term Loan (3 month CME Term SOFR + 5.750%)		11.208		11-16-28		556,340		561,904
OIS Management Services LLC, Revolver (C)		—		11-16-28		167,626		167,626
OIS Management Services LLC, Term Loan (3 month CME Term SOFR + 5.750%)		11.198		11-16-28		1,441,865		1,456,283
Paint Intermediate III LLC, Revolver (C)		—		10-07-27		216,516		216,516
Paint Intermediate III LLC, Term Loan (3 month CME Term SOFR + 5.750%)		11.233		10-06-28		1,948,643		1,963,257
PVI Holdings, Inc., Term Loan (3 month CME Term SOFR + 6.770%)		12.162		01-18-28		2,164,043		2,185,683
Security Services Acquisition Sub Corp., 5th Amendment Delayed Draw Term Loan (1 month CME Term SOFR + 6.000%)		11.457		09-30-26		83,395		82,769
Security Services Acquisition Sub Corp., 5th Amendment Term Loan A (1 month CME Term SOFR + 6.000%) 11.457				09-30-26		116,963		116,086
Security Services Acquisition Sub Corp., 6th Amendment Term Loan A (1 month CME Term SOFR + 6.000%) 11.457				09-30-26		354,158		351,501
Security Services Acquisition Sub Corp., 7th Amendment Delayed Draw Term Loan (1 month CME Term SOFR + 6.000%)		11.457		09-30-26		189,861		188,437
Security Services Acquisition Sub Corp., 8th Amendment Delayed Draw Term Loan (C)		—		09-30-26		1,245,556		1,236,214

See Notes to consolidated financial statements

9

Manulife Private Credit Fund

Schedule of Investments 12-31-23

	Rate (%)		Maturity date			Par value^		Value
Industrials (continued)
Security Services Acquisition Sub Corp., Additional Term Loan A (1 month CME Term SOFR + 6.000%)		11.457		09-30-26			82,356	$	81,738
Security Services Acquisition Sub Corp., Delayed Draw Term Loan (1 month CME Term SOFR + 6.000%)		11.457		09-30-26			97,989		97,254
WWEC Holdings II Corp., Delayed Draw Term Loan (3 month CME Term SOFR + 5.750%)		11.098		10-03-28			339,568		337,021
WWEC Holdings II Corp., Revolver (Prime rate + 4.750%) (C)		13.250		10-03-28			271,654		269,617
WWEC Holdings II Corp., Term Loan (3 month CME Term SOFR + 5.750%)		11.098		10-03-28			1,555,900		1,544,231
XpressMyself.com LLC, Incremental Term Loan (3 month CME Term SOFR + 5.750%)		11.222		09-07-28			597,397		588,436
XpressMyself.com LLC, Revolver (C)		—		09-07-28			233,050		227,224
XpressMyself.com LLC, Term Loan (3 month CME Term SOFR + 5.500%)		10.976		09-07-28			1,334,792		1,301,423
Information technology 3.2%									2,158,633
Alta Buyer LLC, Term Loan (3 month CME Term SOFR + 6.000%)		11.498		12-21-27			2,164,043		2,158,633
Materials 6.5 %									4,293,942
Chemtron Supply LLC, Delayed Draw Term Loan (C)		—		03-02-29			725,959		725,959
Chemtron Supply LLC, Revolver (C)		—		03-02-29			362,979		362,979
Chemtron Supply LLC, Term Loan (3 month CME Term SOFR + 5.750%)		11.098		03-02-29			1,080,308		1,080,308
Krayden Holdings, Inc., Delayed Draw Term Loan A (C)		—		03-01-29			258,694		253,520
Krayden Holdings, Inc., Delayed Draw Term Loan B (C)		—		03-01-29			258,694		253,520
Krayden Holdings, Inc., Revolver (C)		—		03-01-29			272,309		266,863
Krayden Holdings, Inc., Term Loan (3 month CME Term SOFR + 5.750%)		11.198		03-01-29			1,378,360		1,350,793
			Yield (%)			Shares		Value
Short-term investments 29.2% (Cost $19,398,547)								$	19,398,547
Short-term funds 29.2%									19,398,547
Dreyfus Treasury Obligations Cash Management Fund, Institutional Class				4.9800	(D)		19,398,547		19,398,547
Total investments- Non-controlled/Non-affiliated (Cost $77,231,593) 117.1%								$	77,826,436
Less unfunded loan commitments (15.8%)									(10,515,066	)
Net investments- Non-controlled/Non-affiliated (Cost $66,716,527) 101.3%								$	67,311,370
Other assets and liabilities, net (1.3%)									(848,251	)
Total net assets 100.0%								$	66,463,119

The percentage shown for each investment category is the total value of the category as a percentage of the net assets of the Fund.

^ All par values are denominated in U.S. dollars unless otherwise indicated.

See Notes to consolidated financial statements

10

Manulife Private Credit Fund

Schedule of Investments 12-31-23

Security Abbreviations and Legend
CME	CME Group Published Rates
SOFR	Secured Overnight Financing Rate
(A)	Securities are valued using significant unobservable inputs and are classified as Level 3 in the fair value hierarchy. Refer to Note 2 to the consolidated financial statements.
(B)	Senior loans are variable rate obligations which generally pay interest rates that are periodically redetermined by reference to a base lending rate and spread, which are both subject to change. The rate shown represents the rate at period end.
(C)	Unfunded or partially unfunded loan commitments. The stated interest rate reflects the reference rate and spread of the funded portion, if any. No interest rate is determined for unfunded positions. See Note 2 for more information.
(D)	The rate shown is the annualized seven-day yield as of 12-31-23.

At

12-31-23,

the aggregate cost of investments for federal income tax purposes was $66,272,164. Net unrealized appreciation aggregated to $1,039,206, of which $1,111,352 related to gross unrealized appreciation and $72,146 related to gross unrealized depreciation.

See Notes to consolidated financial statements

11

Manulife Private Credit Fund

Consolidated Statements of Assets and Liabilities

	September 30, 2024		December 31, 2023
	(Unaudited)
Assets
Investments – Non-controlled/Non-affiliated, at value (Cost $126,916,085 and $66,716,527, at September 30, 2024 and December 31, 2023, respectively)	$	128,490,788	$	67,311,370
Cash		303,126		95,039
Receivable for investments sold		65,302		115,720
Interest and dividends receivable		832,504		413,164
Receivable from affiliates		—		221,244
Deferred financing cost		1,712,045		—
Other assets		35,785		327,969
Total assets		131,439,550		68,484,506
Liabilities
Credit facility payable		15,000,000		—
Distributions payable		2,343,253		1,491,569
Interest and credit facility expenses payable		369,214		—
Payables to affiliates:
Management fees payable		292,300		56,324
Payable for offering costs		—		129,820
Accounting and legal services fees		13,066		13,758
Trustee fees		—		2,656
Other liabilities and accrued expenses		209,636		327,260
Total liabilities		18,227,469		2,021,387
Net assets	$	113,212,081	$	66,463,119
Net assets consist of
Paid-in capital	$	111,538,568	$	66,538,568
Total distributable earnings (loss)		1,673,513		(75,449	)
Net assets	$	113,212,081	$	66,463,119
Net asset value per share
Based on net assets and shares outstanding - the Fund has an unlimited number of shares authorized with par value of $0.01 per share.
Class NAV:
Net assets	$	113,212,081	$	66,463,119
Shares outstanding		5,360,173		3,204,574
Per share	$	21.12	$	20.74

See Notes to consolidated financial statements

12

Manulife Private Credit Fund

Consolidated Statements of Operations

	For the three months ended			For the nine months ended
	September 30, 2024			September 30, 2024
	(Unaudited)			(Unaudited)
Investment income
From non-controlled/non-affiliated investments:
Interest	$	3,120,423		$	7,482,470
Dividends		105,736			888,917
Other income		42,894			85,499
Total investment income		3,269,053			8,456,886
Expenses
Management fee		359,982			1,015,120
Accounting and legal services fees		16,659			29,747
Trustee fees		19,324			63,253
Professional fees		(133,744	)		470,566
Custody and accounting fees		62,771			169,323
Transfer Agent		2,815			13,367
Printing and postage		—			15,215
Organization cost		—			24,253
Offering cost		6,751			208,618
Interest and credit facility expenses		464,148			940,743
Other expenses		28,967			56,208
Total expenses		827,673			3,006,413
Less expense reductions		68,454			(851,320	)
Net expenses		896,127			2,155,093
Net investment income		2,372,926			6,301,793
Realized and unrealized gain (loss):
Net realized gain (loss) on non-controlled/non-affiliated investments		54,479			60,970
Change in net unrealized appreciation (depreciation) of non-controlled/non-affiliated investments		194,433			979,860
Net realized and unrealized gain (loss)		248,912			1,040,830
Increase (decrease) in net assets from operations	$	2,621,838		$	7,342,623

See Notes to consolidated financial statements

13

Manulife Private Credit Fund

Consolidated Statements of Changes in Net Assets

	For the three months ended			For the nine months ended
	September 30, 2024			September 30, 2024
	(Unaudited)			(Unaudited)
Increase (decrease) in net assets
From operations
Net investment income	$	2,372,926		$	6,301,793
Net realized gain (loss)		54,479			60,970
Change in net unrealized appreciation (depreciation)		194,433			979,860
Increase (decrease) in net assets resulting from operations		2,621,838			7,342,623
Distributions to common shareholders
From earnings
Class NAV		(2,343,253	)		(5,593,661	)
Increase (decrease) from share transactions
Fund shares issued
Class NAV		—			45,000,000
Total increase (decrease)		278,585			46,748,962
Net assets
Beginning of period		112,933,496			66,463,119
End of period	$	113,212,081		$	113,212,081
Share activity
Class NAV shares outstanding
Beginning of period		5,360,173			3,204,574
Shares issued		—			2,155,599
End of period		5,360,173			5,360,173

See Notes to consolidated financial statements

14

Manulife Private Credit Fund

Consolidated Statement of Cash Flows

	For the nine months ended
	September 30, 2024
	(Unaudited)
Cash flows from operating activities
Net increase (decrease) in net assets from operations	$	7,342,623
Adjustments to reconcile net increase (decrease) in net assets from operations to net cash provided by (used in) operating activities
Long-term investments purchased		(90,536,469	)
Long-term investments sold		22,910,425
Net purchases and sales of short-term investments		7,561,689
Net amortization of premium (discount)		(74,233	)
Amortization of deferred financing cost		190,205
(Increase) decrease in assets:
Receivable for investments sold		50,418
Interest and dividends receivable		(419,340	)
Receivable from affiliates		221,244
Other assets		292,184
Increase (decrease) in liabilities:
Payable to affiliates		102,808
Other liabilities and accrued expenses		(117,624	)
Net change in unrealized (appreciation) depreciation of:
Non-controlled/non-affiliated investments		(979,860	)
Net realized (gain) loss on:
Non-controlled/non-affiliated investments		(60,970	)
Net cash provided by (used in) operating activities	$	(53,516,900	)
Cash flows from financing activities
Cash distributions to shareholders	$	(4,741,977	)
Borrowings under the credit facility		20,000,000
Repayments under the credit facility		(5,000,000	)
Financing cost paid		(1,533,036	)
Proceeds from Fund shares issued		45,000,000
Net cash provided by (used in) financing activities	$	53,724,987
Net increase (decrease) in cash	$	208,087
Cash at beginning of period		95,039
Cash at end of period	$	303,126
Supplemental disclosure of cash flow information:
Distributions declared for the period	$	5,593,661
Interest expense paid for the period	$	(96,712	)

See Notes to consolidated financial statements

15

Notes to Consolidated Financial Statements (Unaudited)

Note 1 – Organization

Manulife Private Credit Fund (the Fund) was formed on February 8, 2023 as a Delaware statutory trust and commenced operations on July 17, 2023 concurrent with the initial closing on the Seed Contribution (as defined below). The investment objective of the Fund is to seek to maximize total return in the form of current income and, to a lesser extent, capital appreciation.

Effective October 3, 2023, the Fund elected to be regulated as a business development company (BDC) under the Investment Company Act of 1940, as amended (the 1940 Act) (the date of the Fund’s election to be regulated as a BDC under the 1940 Act is referred to herein as the BDC Election Date) and thereafter operate as a continuously offered, diversified

closed-end

management investment company that has elected to be regulated as a BDC under the 1940 Act. The Fund is a

non-exchange

traded, perpetual-life BDC, which is a BDC whose shares of beneficial interest are not listed for trading on a stock exchange or other securities market. At the sole discretion of the Board of Trustees (the Board or Trustees) of the Fund and provided that it is in the best interest of the Fund and shareholders to do so, the Fund intends to provide a limited degree of liquidity to shareholders by conducting repurchase offers generally quarterly; however, there can be no assurance that any such tender offers will be conducted on a quarterly basis or at all. The Fund currently does not intend to offer to repurchase shares at any time during the first two years of operations of the Fund.

The Fund is only offered to “accredited investors” within the meaning of Regulation D under the Securities Act of 1933, as amended (the Securities Act),

non-U.S.

investors within the meaning of Regulation S under the Securities Act, and other investors eligible to invest in a private placement.

On July 17, 2023, Manulife International Limited (Hong Kong) and Manufacturers Life Reinsurance Limited (collectively, the Sponsors) invested an aggregate of approximately $41.2 million in the Fund (Seed Contribution). The Sponsors received an aggregate of approximately 2.1 million shares of the Fund at $20.00 per share, which represented all the issued and outstanding shares of the Fund on that date. The Fund commenced operations concurrent with the initial closing on the Seed Contribution. Immediately following the closing of the Seed Contribution, the Fund entered into a purchase agreement with John Hancock Funding Company, LLC (JH Funding) to acquire an initial seed portfolio of assets which consisted of approximately $50 million in total par value of senior loan investments, including both funded loans and unfunded commitments.

Note 2 – Significant accounting policies

Basis of Consolidation

Manulife Private Credit Fund SPV, LLC (the SPV) is a Delaware limited liability company that was formed on December 11, 2023. The SPV, which holds certain of the Fund’s portfolio loan investments that are used as collateral for the credit facility, is a wholly owned subsidiary of the Fund. The SPV commenced operations on March 26, 2024 upon receipt of a contribution of portfolio loan investments from the Fund.

As provided under Accounting Standards Codification (ASC) 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiary, the SPV. All significant intercompany balances and transactions have been eliminated in consolidation.

The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (US GAAP), which require management to make certain estimates and assumptions as of the date of the consolidated financial statements. Actual results could differ from those estimates and those differences could be significant. The Fund qualifies as an investment company under ASC 946 of US GAAP.

Certain financial information that is included in annual financial statements, including certain financial statement disclosures, prepared in accordance with US GAAP, is not required for interim reporting purposes and has been condensed or omitted herein. These consolidated financial statements should be read in conjunction with the Fund’s audited financial statements and notes related thereto for the period from July 17, 2023 (inception) to December 31, 2023, included in the Fund’s Form

10-K

filing. The results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year, any other interim period or future year or period.

The following summarizes the significant accounting policies of the Fund:

Security valuation.

Investments are valued at the end of each month at a minimum. The Fund invests primarily in senior loans. Manulife Investment Management Private Markets (US) LLC (the Advisor), assisted by its Pricing Committee (composed of officers of the Advisor and its affiliates), as designated by the Board, determines the fair value of the Fund’s securities that are not publicly traded or whose market prices are not readily available pursuant to procedures established by the Advisor and adopted by the Board. In connection with that determination, portfolio valuations are prepared in accordance with the Advisor’s valuation policy using valuations obtained from independent valuation firms and/or proprietary models.

Valuation techniques include discounted cash flow models, comparison with similar instruments for which observable market prices exist and other valuation models. Assumptions and inputs used in valuation techniques include risk-free and benchmark interest rates, credit spreads and other inputs used in estimating discount rates. For senior loans, the Fund uses valuations from independent valuation firms, which are based on models developed from recognized US GAAP valuation approaches under ASC 820. Some or all of the significant inputs into these models may be unobservable and are derived either from observable market prices or rates or are estimated based on unobservable assumptions. Valuation models that employ significant

16

unobservable inputs require a higher degree of management judgment and estimation in the determination of fair value. Judgment and estimation are usually required for the selection of the appropriate valuation model to be used, determination of expected future cash flows on the financial instrument being valued, determination of the probability of counterparty default and prepayments and selection of appropriate discount rates.

The Fund uses a three-tier hierarchy to prioritize the pricing assumptions, referred to as inputs, used in valuation techniques to measure fair value. Level 1 includes securities valued using quoted prices in active markets for identical securities. Level 2 includes securities valued using other significant observable inputs. Observable inputs may include quoted prices for similar securities, interest rates, prepayment speeds and credit risk. Prices for securities valued using these inputs are received from independent pricing vendors and brokers and are based on an evaluation of the inputs described. Level 3 includes securities valued using significant unobservable inputs when market prices are not readily available or reliable, including the Advisor’s own assumptions in determining the fair value of investments. Factors used in determining value may include market or issuer specific events or trends, changes in interest rates and credit quality. The inputs or methodology used for valuing securities are not necessarily an indication of the risks associated with investing in those securities. Changes in valuation techniques and related inputs may result in transfers into or out of an assigned level within the disclosure hierarchy.

Senior loan investments are measured at fair value based on the present value of the expected cash flows of the loans. There are no quoted prices in active markets. Assumptions and inputs used in the valuation of senior loan investments include prepayment estimates, determination of the discount rate based on the risk-free interest rate adjusted for credit risk (including estimation of probability of default), liquidity and any other adjustments that the independent valuation firm believes that a third-party market participant would take into account in pricing a transaction. Senior loan investment valuations rely primarily on the use of significant unobservable inputs, including credit assumptions, which require significant judgment and, accordingly, are classified as Level 3.

Investments in

open-end

mutual funds are valued at their respective net asset values each business day and are generally classified as Level 1.

The following is a summary of the values by input classification of the Fund’s investments as of September 30, 2024 and December 31, 2023, by major security category or type:

	Total value at		Level 1		Level 2 Significant observable inputs		Level 3 Significant unobservable inputs
	9-30-24		Quoted price
Investments in securities:
Assets
Senior loans (less unfunded loan commitments)	$	116,653,930		—		—	$	116,653,930
Short-term investments		11,836,858	$	11,836,858		—		—
Total investments in securities	$	128,490,788	$	11,836,858		—	$	116,653,930

	Total value at 12-31-23		Level 1 Quoted price		Level 2 Significant observable inputs		Level 3 Significant unobservable inputs
Investments in securities:
Assets
Senior loans (less unfunded loan commitments)	$	47,912,823		—		—	$	47,912,823
Short-term investments		19,398,547	$	19,398,547		—		—
Total investments in securities	$	67,311,370	$	19,398,547		—	$	47,912,823

The Fund holds liabilities for which the carrying amount approximates the fair value for financial statement purposes. As of September 30, 2024, the liability for the Fund’s Credit facility payable on the Consolidated Statements of Assets and Liabilities is categorized as Level 2 within the disclosure hierarchy. There was no Credit facility payable as of December 31, 2023.

17

The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value. There were no transfers into or out of Level 3 during the nine months ended September 30, 2024.

Investments in securities	Senior loans
Beginning balance as of 12-31-23	$	47,912,823
Purchases and drawdowns		90,536,469
Sales and paydowns		(22,910,425	)
Net amortization of (premium) discount		74,233
Realized gain (loss)		60,970
Change in unrealized appreciation (depreciation)		979,860
Ending balance as of 9-30-24	$	116,653,930
Change in unrealized appreciation (depreciation) at period end*	$	1,027,860

* Change in unrealized appreciation (depreciation) attributable to Level 3 securities held at the period end.

The valuation techniques and significant unobservable inputs used in the fair value measurement of the Fund’s Level 3 securities are outlined in the tables below.

	Fair Value at 9-30-24		Valuation Technique		Significant Unobservable Inputs		Input Range		Input Weighted Average*
Senior Loans	$	114,021,430		Discounted cash flow		Discount rate		8.52% -12.65%		9.68	%
Senior Loans		2,632,500		Recent transaction		Transaction price		$98.50	$	98.50
	$	116,653,930

	Fair Value at 12-31-23		Valuation Technique	Significant Unobservable Inputs	Input Range	Input Weighted Average*
Senior Loans	$	40,053,210	Discounted cash flow	Discount rate	9.90% - 12.47%		10.92	%
Senior Loans	$	7,859,613	Recent transaction	Transaction price	$98.00 - $100	$	98.81
	$	47,912,823

* A weighted average is an average in which each input in the grouping is assigned a weighting before summing to a single average value. The weighting of the input is determined based on a security’s fair value as a percentage of the total fair value.

A change to unobservable inputs of the Fund’s Level 3 securities as of September 30, 2024 and December 31, 2023 could have resulted in changes to the fair value measurement, as follows:

Significant Unobservable Input	Impact to Valuation if input had increased	Impact to Valuation if input had decreased
Discount rate	Decrease	Increase
Transaction price	Increase	Decrease

18

Due to the inherent uncertainty of determining the fair value of Level 3 investments, the fair value of the investments may differ significantly from the values that would have been used had a ready available market value for such securities existed and may differ materially from the values that may ultimately be received or settled. Further, such investments will generally be subject to legal and other restrictions, or otherwise will be less liquid than publicly traded instruments. If the Fund is required to liquidate a portfolio investment in a forced or liquidation sale, the Fund might realize significantly less than the value at which such investment will have been previously been recorded. The Fund’s investments will be subject to market risk. Market risk is the potential for changes in the value due to market changes. Market risk is directly impacted by the volatility and liquidity in the markets in which the investments are traded.

Investments.

The Fund invests primarily in the debt of private middle-market U.S. companies with a focus on directly originated first and second lien loans (including delayed draw term loans and revolving credit facilities). The Fund’s investments (excluding unfunded loan commitments), consisted of the following:

	September 30, 2024							December 31, 2023
	Amortized Cost		Fair Value		% of Investments at Fair Value			Amortized Cost		Fair Value		% of Investments at Fair Value
First-Lien Loans	$	115,079,227	$	116,653,930		90.8	%	$	47,317,980	$	47,912,823		71.2	%
Other Securities		11,836,858		11,836,858		9.2	%		19,398,547		19,398,547		28.8	%
Total Investments	$	126,916,085	$	128,490,788		100.0	%	$	66,716,527	$	67,311,370		100.0	%

19

The sector composition of investments at fair value as a percentage of net assets as of September 30, 2024 and December 31, 2023, was as follows:

Sector Composition	As of 9-30-24 (% of net assets)			As of 12-31-23 (% of net assets)
Industrials		64.0			48.3
Health care		26.5			12.7
Consumer discretionary		24.9			9.5
Information technology		7.7			3.2
Consumer staples		6.6			4.5
Materials		3.9			6.5
Financials		1.9			3.2
Short-term investments and other (less unfunded loan commitments)		(35.5	)		12.1
		100			100

Percentages include unfunded loan commitments.

The industry composition of investments at fair value as a percentage of net assets as of September 30, 2024 was as follows:

Industry Composition as of 9-30-24 (% of net assets)
Commercial services and supplies	26.0
Trading companies and distributors	23.5
Health care providers and services	23.2
Professional services	7.7
Hotels, restaurants and leisure	7.4
Consumer staples distribution and retail	6.6
Diversified consumer services	6.5
IT services	4.6
Chemicals	3.9
Air freight and logistics	3.9
Specialty retail	3.9
Leisure products	3.5
Health care equipment and supplies	3.3
Software	3.1
Building products	2.9
Capital markets	1.9
Automobile components	1.9
Textiles, apparel and luxury goods	1.7
Short-term investments and other (less unfunded loan commitments)	(35.5	)
	100

Percentages include unfunded loan commitments.

As of September 30, 2024 and December 31, 2023, 100% of investments held were based in the United

States.

20

Senior loans.

The Fund invests in senior loans. Senior loans include first and second lien term loans, delayed draw term loans, and revolving credit facilities. The Fund will only invest in loans and commitments that are determined to be below investment-grade, based on credit quality, as determined by the Advisor, at the time of purchase. The Fund will invest in first lien, senior secured loans and senior secured bonds that generally have stated terms of five to seven years, and subordinated debt investments (to a lesser extent) that generally have stated terms of up to nine years, but the expected average life of such securities is generally two to four years. However, the Fund may invest in loans and securities with any maturity or duration. The Advisor typically expects to employ a

buy-and-hold

strategy. The Fund may invest in loans either by transacting directly at the initial funding date or acquiring loans in secondary market transactions. The Fund may invest in loans secured by substantially all of the assets of the borrower and the other loan parties, subject to customary exceptions, including a pledge of the equity of the borrower and its subsidiaries.

The Fund may be subject to greater levels of credit risk, call (or prepayment) risk, settlement risk and liquidity risk than funds that do not invest in senior loans. Senior loans are considered predominantly speculative with respect to an issuer’s continuing ability to make principal and interest payments, and may be more volatile than other types of securities. An economic downturn or individual corporate developments could adversely affect the market for these instruments and reduce the Fund’s ability to sell these instruments at an advantageous time or price. An economic downturn would generally lead to a higher

non-payment

rate and a senior loan may lose significant value before a default occurs. The Fund may also be subject to greater levels of liquidity risk than funds that do not invest in senior loans. In addition, the senior loans in which the Fund invests may not be listed on any exchange and a secondary market for such loans may be comparatively less liquid relative to markets for other more liquid fixed income securities. Consequently, transactions in senior loans may involve greater costs than transactions in more actively traded securities. Restrictions on transfers in loan agreements, a lack of publicly available information, irregular trading activity and wide bid/ask spreads among other factors, may, in certain circumstances, make senior loans difficult to value accurately or sell at an advantageous time or price than other types of securities or instruments. These factors may result in the Fund being unable to realize full value for the senior loans and/or may result in the Fund not receiving the proceeds from a sale of a senior loan for an extended period after such sale, each of which could result in losses to the Fund. Senior loans may have extended trade settlement periods which may result in cash not being immediately available to the Fund. If an issuer of a senior loan prepays or redeems the loan prior to maturity, the Fund may have to reinvest the proceeds in other senior loans or similar instruments that may pay lower interest rates. Senior loans in which the Fund invests may or may not be collateralized, although the loans may not be fully collateralized and the collateral may be unavailable or insufficient to meet the obligations of the borrower. The Fund may have limited rights to exercise remedies against such collateral or a borrower, and loan agreements may impose certain procedures that delay receipt of the proceeds of collateral or require the Fund to act collectively with other creditors to exercise its rights with respect to a senior loan. Because of the risks involved in investing in senior loans, an investment in the Fund should be considered speculative. Junior loans, which are secured and unsecured subordinated loans, second lien loans and subordinate bridge loans, involve a higher degree of overall risk than senior loans of the same borrower due to the junior loan’s lower place in the borrower’s capital structure and, in some cases, their unsecured status.

The Fund may also enter into, or acquire participations in, delayed funding loans and revolving credit facilities, in which a bank or other lender agrees to make loans up to a maximum amount upon demand by the borrower during a specified term. These commitments may have the effect of requiring the Fund to increase its investment in a company at a time when it might not be desirable to do so (including at a time when the company’s financial condition makes it unlikely that such amounts will be repaid). Delayed funding loans and revolving credit facilities are subject to credit, interest rate and liquidity risk and the risks of being a lender. Unfunded loan commitments are marked to market in accordance with the Fund’s valuation policies. Any related unrealized appreciation (depreciation) on unfunded commitments is included in

non-controlled/non-affiliated

investments, at value in the Consolidated Statements of Assets and Liabilities and change in net unrealized appreciation (depreciation) in the Consolidated Statements of Operations.

21

As of September 30, 2024 and December 31, 2023, the Fund had the following unfunded commitments outstanding:

	September 30, 2024							December 31, 2023
Unfunded term loan	Principal on delayed draw term loan		Principal on revolver		Unrealized Appreciation (Depreciation)			Principal on delayed draw term loan		Principal on revolver		Unrealized Appreciation (Depreciation)
4M Capital, Ltd.		—	$	528,000	$	3,631			—		—		—
Air Buyer, Inc.	$	750,000		340,909		(6,563	)		—		—		—
American Combustion Industries, Inc.		1,005,670		359,168		(3,232	)		—		—		—
Bandon Fitness, Inc.		1,818,352		114,804		17,345		$	191,049	$	45,462	$	1,774
BCTS Parent LLC		824,176		283,587		13,913			974,832		283,587		12,584
Beary Landscaping LLC		422,535		405,634		(6,296	)		422,535		422,535		(4,225	)
BLP Buyer, Inc.		—		268,548		4,700			290,323		268,548		(2,903	)
Capital Construction LLC		243,639		508,039		14,874			—		161,862		3,642
Chemtron Supply LLC		2,333,630		362,979		4,719			725,959		362,979		25,045
CPC Lakeshirts Acquisition LLC		—		316,689		10,292			258,419		329,357		(17,634	)
Diverzify Intermediate LLC		1,371,429		—		6,857			—		—		—
Gannet Fleming, Inc.		—		—		—			—		297,877		5,421
Health Management Associates, Inc.		155,005		105,403		6,771			210,806		124,004		6,194
Hill Country Dairies, Inc.		1,088,710		689,516		(6,315	)		—		—		—
In Vitro Sciences LLC		7,111		177,778		(4,232	)		—		—		—
Jetson Buyer, Inc.		—		399,290		1,997			—		—		—
Krayden Holdings, Inc.		1,393,071		574,269		31,090			517,388		272,309		7,897
Leap Service Partners LLC		905,882		382,353		14,617			—		—		—
Library Associates LLC		—		24,139		337			—		72,418		651
Lockmasters Security Intermediate, Inc.		878,274		205,895		4,769			—		—		—
M&D Midco, Inc.		352,239		125,337		1,441			233,629		225,607		6,429
Midwest Eye Services LLC		—		142,385		4,414			—		142,385		142
OIS Management Services LLC		2,053,991		167,626		(335	)		—		167,626		503
Paint Intermediate III LLC		—		81,193		1,299			—		216,516		3,464
Pak Quality Foods Acquisition LLC		537,313		313,433		11,642			537,313		268,657		—
PNB Holdings III LLC		1,227,273		572,727		(9,204	)		—		—		—
Refocus Management Services LLC		747,368		210,526		9,579			—		—		—
Renovation Systems LLC		1,096,996		68,894		17,832			—		—		—
RPC TopCo, Inc.		—		545,455		—			—		—		—
Security Services Acquisition Sub Corp.		—		—		—			1,245,556		—		23,043
Star Logistics & Hospitality Services LLC		1,607,143		482,143		25,715			—		—		—
Steward Partners Global Advisory LLC		406,790		311,716		16,525			480,043		311,716		8,313
SurfacePrep Buyer LLC		547,945		479,452		16,438			—		—		—
The Smilist DSO LLC		280,069		140,351		2,455			—		—		—
VPD Management, Inc.		3,028,571		228,571		32,572			—		—		—
WeLocalize, Inc.		—		224,852		(2,811	)		—		—		—
WWEC Holdings III Corp.		824,818		434,020		19,259			—		220,719		2,318
XpressMyself.com LLC		—		233,050		5,710			—		233,050		2,797
Total	$	25,908,000	$	10,808,731	$	261,805		$	6,087,852	$	4,427,214	$	85,455

22

Security transactions and related investment income. Investment security transactions are accounted for on a trade date plus one basis for net asset value (NAV) calculations. However, for financial reporting purposes, investment transactions are reported on trade date. Interest income is accrued as earned. Interest income includes coupon interest and amortization/accretion of premiums/discounts on debt securities. Debt obligations may be placed in a

non-accrual

status and related interest income may be reduced by stopping current accruals and writing off interest receivable when the collection of all or a portion of interest has become doubtful. Dividend income is recorded on

ex-date.

Certain senior loan related fees, such as amendment fees, are recorded as Other income when earned. Gains and losses on securities sold are determined on the basis of identified cost and may include proceeds from litigation.

Overdraft.

Pursuant to the custodian agreement, the Fund’s custodian may, in its discretion, advance funds to the Fund to make properly authorized payments. When such payments result in an overdraft, the Fund is obligated to repay the custodian for any overdraft, including any costs or expenses associated with the overdraft. The custodian may have a lien, security interest or security entitlement in any Fund property that is not otherwise segregated or pledged, to the maximum extent permitted by law, to the extent of any overdraft.

Expenses.

Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

Offering and Organization Costs

Organization costs are expensed as incurred. During the three and nine months ended September 30, 2024, the Fund incurred organization costs of $0 and $24,253, respectively. Offering costs are accounted for as a deferred charge by the Fund and will be amortized to expense over 12 months from the BDC Election Date. During the three and nine months ended September 30, 2024, $6,751 and $208,618, respectively, of offering costs were expensed. As of September 30, 2024 and December 31, 2023, $0 and $325,450, respectively of unamortized offering costs are included in Other assets within the Consolidated Statements of Assets and Liabilities.

Consolidated Statement of Cash Flows.

A Statement of Cash Flows is presented when a certain percentage of the Fund’s investments is classified as Level 3 in the fair value hierarchy. Information on financial transactions that have been settled through the receipt and disbursement of cash is presented in the Consolidated Statement of Cash Flows. The cash amount shown in the Consolidated Statement of Cash Flows is the amount included in the Fund’s Consolidated Statements of Assets and Liabilities and represents the cash on hand at the Fund’s custodian and does not include any short-term investments.

Federal income taxes.

The Fund has elected and intends to qualify as a regulated investment company by complying with the applicable provisions of the Internal Revenue Code and will not be subject to federal income tax on taxable income that is distributed to shareholders. Therefore, no federal income tax provision is required.

Due to certain Internal Revenue Code rules, future realized gain/loss may be offset by built in gains acquired from when the entity was a partnership.

As of December 31, 2023, the Fund had no uncertain tax positions that would require financial statement recognition, derecognition or disclosure. The Fund’s federal tax returns once filed are subject to examination by the Internal Revenue Service for a period of three years.

Distribution of income and gains.

Distributions to shareholders from net investment income and net realized gains, if any, are recorded on the

ex-date.

The Fund generally declares and pays dividends quarterly. Capital gain distributions, if any, are typically distributed annually.

Such distributions, on a tax basis, are determined in conformity with income tax regulations, which may differ from US GAAP. Distributions in excess of tax basis earnings and profits, if any, are reported in the Fund’s consolidated financial statements as a return of capital. The final determination of tax characteristics of the Fund’s distribution will occur at the end of the year and will subsequently be reported to shareholders.

Capital accounts within the consolidated financial statements are adjusted for permanent

book-tax

differences. These adjustments have no impact on net assets or the results of operations. Temporary

book-tax

differences, if any, will reverse in a subsequent period.

Book-tax

differences are primarily attributable to partnership tracking.

23

Note 3 – Guarantees and indemnifications

Under the Fund’s organizational documents, its officers and Trustees are indemnified against certain liabilities arising out of the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund may enter into contracts with service providers that contain general indemnification clauses. The Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred. The risk of material loss from such claims is considered remote.

Note 4 – Agreements and transactions with related parties

Manulife Investment Management Private Markets (US) LLC (the Advisor) serves as investment advisor for the Fund. The Fund does not have a principal underwriter. The Fund has entered into a Placement Agency Agreement with John Hancock Investment Management Distributors LLC (the Distributor), an affiliate of the Advisor, to offer to sell shares of the Fund. The Advisor is an indirect wholly-owned subsidiary of Manulife Financial Corporation (MFC), and the Distributor is an indirect, principally owned subsidiary of John Hancock Life Insurance Company (U.S.A.), which in turn is a subsidiary of

MFC.

Management fee.

The Fund has an investment management agreement with the Advisor (the Investment Advisory Agreement) under which the Fund pays an annual fee rate of 1.25% of monthly net assets effective on and after October 3, 2023. The management fee is payable monthly in

arrears.

The Advisor contractually agrees to limit its management fee for the Fund (excluding any incentive fee) to an annual rate of 1.00% of monthly net assets. This agreement expires on October 3, 2025, unless renewed by mutual agreement of the Advisor and the Fund based upon a determination that this is appropriate under the circumstances at

that time.

The Advisor contractually agrees to reduce the Fund management fee, or, if necessary, make payment to the Fund, in an amount equal to the amount by which the expenses of the Fund, incurred in the ordinary course of the Fund’s business, exceed 0.50% of monthly net assets (on an annualized basis) of the Fund (the Expense Limitation and Reimbursement Agreement). For purposes of the Expense Limitation and Reimbursement Agreement, “expenses of the Fund” means all expenses of the Fund, excluding (a) management and incentive fees, (b) interest expense and other borrowing related costs, fees and expenses, (c) taxes, (d) portfolio brokerage commissions, (e) litigation and indemnification expenses and other extraordinary expenses not incurred in the ordinary course of the business of the Fund, (f) short dividends and (g) cashiering or other investment servicing fees. This agreement expires on October 3, 2025, unless renewed by mutual agreement of the Advisor and the Fund based upon a determination that this is appropriate under the circumstances at that

time.

The expense reductions described above amounted to $(68,454) and $851,320 for the three and nine months ended September 30, 2024,

respectively.

Expenses waived or reimbursed in the current fiscal period are not subject to recapture in future fiscal

periods.

The management fee, including the impact of the waivers and reimbursements as described above, incurred for the three and nine months ended September 30, 2024, was equivalent to a net annual effective rate of 1.50% and 0.21%, respectively, of the Fund’s average monthly

net assets.

Incentive fee.

The Fund has agreed to pay the Advisor an incentive fee commencing on and after October 3, 2024. A portion of the incentive fee is based upon

pre-incentive

fee net investment income and a portion is based on capital gains. The incentive fee shall be calculated and accrued on a monthly basis while being determined and payable in arrears as of the end of each fiscal quarter. During the three and nine months ended September 30, 2024, there was no incentive fee charged as commencement of the incentive fee has not yet

occurred.

Accounting and legal services.

The Fund has entered into a service agreement with the Advisor (the Service Agreement), under which the Advisor is responsible for providing, at the expense of the Fund, various administrative, accounting and legal services, including treasury, valuation, and portfolio and cash management services. Pursuant to a separate service level agreement between the Advisor and John Hancock Investment Management LLC (JHIM), JHIM is responsible for providing certain financial, accounting and administrative services such as legal, tax, accounting, financial reporting and performance, compliance and service provider oversight services. The Fund shall reimburse the Advisor for all expenses associated with providing all such financial, accounting and administrativ

e

services.

These accounting and legal services fees incurred for the three and nine months ended September 30, 2024 amounted to an annual rate of 0.06% and 0.04%, respectively, of the Fund’s average monthly

net assets.

Trustee expenses. The Fund compensates each Trustee who is not an employee of the Advisor or its affiliates. 

Co-investment.

Pursuant to an Exemptive Order issued by the SEC, the Fund is permitted to negotiate certain investments with entities with which it would be restricted from doing so under the 1940 Act, such as the Advisor and its affiliates. The Fund is permitted to

co-invest

with affiliates if certain conditions are met. For example, the Advisor makes an independent determination of the appropriateness of the investment for the Fund. Also, a “required majority” (as defined in the 1940 Act) of the Fund’s independent Trustees make certain conclusions in connection with a

co-investment

transaction as set forth in the Exemptive Order, including that (1) the terms of the transactions, including the consideration to be paid, are reasonable and fair to the Fund and shareholders and do not involve overreaching by the Fund or shareholders on the part of any person concerned and (2) the transaction is consistent with the interests of shareholders and is consistent with the Fund’s investment objective and strategies.

24

During the three and nine months ended September 30, 2024, commitments entered into by the Fund pursuant to the Exemptive Order amounted to $29,314,665 and $97,363,296 including unfunded commitments of $11,248,706 and $29,269,769

r

espectivel

y.

Note 5 – Borrowings

On July 26, 2023, the Board and the Fund’s sole shareholder approved the application of the reduced asset coverage requirements in Section 61(a)(2) of the 1940 Act to the Fund and such election became effective the following day. As a result of this approval, the Fund’s applicable minimum asset coverage ratio under the 1940 Act was decreased to 150% from 200% and the Fund is currently allowed to borrow amounts such that its asset coverage ratio, as defined in the 1940 Act, is at least 150% after such borrowing (if certain requirements are met). As of September 30, 2024, the asset coverage ratio was 855%.

JPM Funding Facility

On March 26, 2024, Manulife Private Credit Fund SPV, LLC, a wholly owned consolidated subsidiary of the Fund, entered into a Loan and Security Agreement (the JPM Funding Facility), as borrower (the Borrower), with the Fund, as the parent and portfolio manager, The Bank of New York Mellon Trust Company, National Association, as collateral agent, collateral administrator and securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provides a secured credit facility of up to $150 million with a reinvestment period ending March 26, 2027 and a final maturity date of March 26, 2029. The JPM Funding Facility also provides for a feature that allows the Borrower, subject to certain conditions, to increase the overall size of the JPM Funding Facility to a maximum of $500 million. In addition, on March 26, 2024, the Fund, as seller, and the Borrower, as purchaser, entered into a Sale and Contribution Agreement, pursuant to which the Borrower will either purchase certain corporate loans or receive contributions of cash or such corporate loans, (collectively, the Loans), from time to time, originated by the Fund or its affiliates.

The obligations of the Borrower under the JPM Funding Facility are secured by substantially all assets held by the Borrower, including the Loans. Borrowings under the JPM Funding Facility will bear interest at Term SOFR or an alternate base rate, in each case plus an applicable margin equal to 2.70%, subject to increases for default rate interest from time to time pursuant to the terms of the JPM Funding Facility. In addition, the Borrower will pay, among other fees, an upfront fee, an administrative agency fee and a commitment fee on the undrawn balance of 0.55% per annum (or, during the March 26, 2024 to March 27, 2025

ramp-up

period, 0.30% per annum) on the average daily unused facility amount.

Under the JPM Funding Facility, the Fund and the Borrower, as applicable, have made customary representations and warranties regarding their businesses, among other things, and are required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities. The JPM Funding Facility includes usual and customary events of default for such facilities of this nature. Proceeds from the JPM Funding Facility must be used for the purposes permitted in the JPM Funding Facility, including purchasing of loans or other portfolio investments.

As of September 30, 2024, the Fund had outstanding borrowings of $15,000,000 at an average interest rate of 7.60%, which is reflected in the Credit facility payable on the Consolidated Statements of Assets and Liabilities. During the three and nine months ended September 30, 2024, the average daily outstanding borrowings for the JPM Funding Facility amounted to $5,197,183 and $4,386,905 and the weighted average interest rate was 7.78% and 7.89%, respectively.

The Fund recorded the following interest expense, unused commitment fee and other credit facility related fees on the JPM Funding Facility as Interest and credit facility expenses on the Consolidated Statements of Operations during the three and nine months ended September 30, 2024:

	Three months ended		Nine months ended
	September 30, 2024		September 30, 2024
Interest expense	$	79,756	$	161,562
Unused commitment fee and administration fee		192,542		384,681
Other credit facility related fees		116,316		239,327
	$	388,614	$	785,570

In connection with the JPM Funding Facility, the SPV pays an upfront fee which is deferred and amortized over the life of the JPM Funding Facility using the straight-line method. During the three and nine months ended September 30, 2024, $75,534 and $155,173

of the upfront fee was expensed and included in Interest and credit facility expenses and $20,619 and $35,032 of related upfront legal fees was expensed and included in Professional fees on the Consolidated Statements of Operations and at September

30, 2024, $1,712,045 of unamortized upfront fee is included in Deferred financing cost on the Consolidated Statements of Assets and Liabilities. During the three months ended September 30, 2024, legal fees related to establishing the JPM Funding Facility were capitalized and are being amortized over the life of the facility, and therefore, professional fees have been adjusted accordingly.

JH Funding Revolving Promissory Note Agreement

On July 17, 2023, the Fund entered into a revolving promissory note agreement with JH Funding. The aggregate outstanding borrowings under the agreement with JH Funding for the Fund would not exceed $30 million. There were no upfront fees or commitment fees paid by the Fund in connection with the agreement. As of September 30, 2024 and December 31, 2023, the Fund did not have any borrowings outstanding under the agreement with JH Funding. The agreement terminated upon the effective date of the JPM Funding Facility on March 26, 2024.

25

Note 6 – Shares of beneficial interest

At September 30, 2024, affiliates of the Fund, Manulife International Limited (Hong Kong), Manufacturers Life Reinsurance Limited and Manulife Private Credit Plus Fund owned 32.4%, 13.9% and 53.7%, respectively, of the Class NAV shares of beneficial interest outstanding.

At December 31, 2023, affiliates of the Fund, Manulife International Limited (Hong Kong), Manufacturers Life Reinsurance Limited and Manulife Private Credit Plus Fund owned 54.2%, 23.3% and 22.5%, respectively, of the Class NAV shares of beneficial interest outstanding.

Note 7 – Purchase and sale of securities

Purchases and sales of securities, other than short-term investments, amounted to $90,536,469 and $22,910,425, respectively, for the nine months ended September 30, 2024.

Note 8 – Consolidated Financial Highlights

	For the nine months ended September 30, 2024 Class NAV
Per share operating performance
Net asset value, beginning of period	$	20.74
Net investment income (1)		1.23
Net realized and unrealized gain (loss) on investments		0.19
Total from investment operations		1.42
Less distributions to common shareholders
From investment income		(1.04	)
Total distributions		(1.04	)
Net asset value, end of period	$	21.12
Total return (%) (2),(3)		7.05	%
Ratios and supplemental data
Net assets, end of period (in millions)	$	113
Ratios (as a percentage of average net assets):
Expenses before reductions (4)		3.70	%
Expenses including reductions (4)		2.65	%
Expenses including reductions (excluding interest and credit facility expenses) (4)		1.50	%
Net investment income (4)		7.75	%
Portfolio turnover		27	%
Total debt outstanding end of period (in millions)	$	15
Asset coverage per $1,000 of debt, end of period (5)	$	8,547

(1) Based on average monthly shares outstanding.

(2) Not annualized.

(3) Total return would have been lower had certain expenses not been reduced during the applicable period.

(4) Annualized.

(5) Asset coverage equals the total net assets plus borrowings divided by the borrowings of the Fund outstanding at period end (Note 5). As debt outstanding changes, the level of invested assets may change accordingly. Asset coverage ratio provides a measure of leverage.

Note 9 – Subsequent Events

Events or transactions occurring after the end of the period through the date that the consolidated financial statements were issued have been evaluated in the preparation of the consolidated financial statements. The Fund has concluded that there is no impact requiring adjustment or disclosure in the consolidated financial statements.

26

CERTAIN DEFINITIONS

Unless indicated otherwise in this quarterly report on Form

10-Q

or the context requires otherwise, the terms “we,” “us,” “our,” and the “Fund” refer to Manulife Private Credit Fund. The terms “Advisor” and our “Investment Advisor” refers to Manulife Investment Management Private Markets (US) LLC, our investment advisor.

FORWARD-LOOKING

STATEMENTS

This report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and you should not place undue reliance on such statements. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about us, our current and prospective portfolio investments, our industry, our beliefs and opinions and our assumptions. We are externally managed by the Advisor, a registered investment advisor under the Investment Advisers Act of 1940, as amended, which is an indirect wholly-owned subsidiary of Manulife Financial Corporation (Manulife). Manulife does not have any obligation, contractual or otherwise, to financially support us beyond the Seed Contribution (as defined below) of certain of their affiliates. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “potential,” “predicts,” and variations of these words and similar expressions are intended to identify

forward-looking

statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the

forward-looking

statements, including:

• our future operating results;

• our business prospects and the prospects of our portfolio companies;

• risk associated with possible disruptions in our operations or the economy generally, including disruptions from the impact of a global pandemic;

• changes in the general interest rate environment;

• general economic, political and industry trends and other external factors, including uncertainty surrounding the financial and political stability of the United States and other countries;

• our contractual arrangements and relationships with third parties;

• actual and potential conflicts of interest with our Advisor and its affiliates;

• the dependence of our future success on the general economy and its effect on the industries in which we invest;

• the ability of our portfolio companies to achieve their objectives;

• the use of borrowed money to finance a portion of our investments;

• the adequacy of our financing sources and working capital;

• the timing and amount of cash flows, if any, from the operations of our portfolio companies;

• the ability of our Advisor to locate suitable investments for us and to monitor and administer our investments;

• the ability of our Advisor and its affiliates to attract and retain highly talented professionals;

• our ability to qualify and maintain our qualification as a business development company and as a regulated investment company under the Internal Revenue Code of 1986, as amended;

• the impact on our business of U.S. and international financial reform legislation, rules and regulations; and

• the effect of changes in tax laws and regulations and interpretations thereof.

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of the assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statements in this report should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in the section entitled “Risk Factors” in Part I, Item 1A of our Annual Report on Form

10-K

for the year ended December 31, 2023 as updated by the Fund’s periodic filings with the United States Securities and Exchange Commission (the SEC). You should not place undue reliance on these forward-looking statements, which apply only as of the date of this report. Moreover, we assume no duty and do not undertake to update the forward-looking statements. You are advised to consult any additional disclosures that we make directly to you or through reports that we may file with the SEC in the future, including annual reports on Form

10-K,

quarterly reports on Form

10-Q

and current reports on Form

8-K.

27

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The information in this section contains forward-looking statements that involve risks and uncertainties, including, but not limited to, those set forth in “Part I Item 1A. Risk Factors” of our annual report for the fiscal year ended December 31, 2023 on Form 10-K. You should read the following discussion in conjunction with the Part I, Item 1 of this Form 10-Q “Consolidated Financial Statements (Unaudited)” and related notes thereto and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. This discussion also should be read in conjunction with the “Forward-Looking Statements” in this Quarterly Report on Form 10-Q.

The following discussion and analysis of our financial condition and results of operations is intended to provide a better understanding of our consolidated financial statements, including a brief discussion of our business, key factors that impacted our performance and a summary of our operating results. Historical results and percentage relationships among any amounts in the consolidated financial statements are not necessarily indicative of trends in operating results for any future periods.

Overview

We are an externally managed, diversified closed-end management investment company that has elected to be regulated as a BDC under the 1940 Act. Formed as a Delaware statutory trust on February 8, 2023, we are externally managed by the Advisor, which manages our day-to-day operations and provides us with investment advisory and administrative services pursuant to the terms of the Investment Advisory Agreement, and the Service Agreement with the Fund and the Service Level Agreement between the Advisor and JHIM. The Advisor is registered as investment advisor with the SEC. We have elected to be treated as a regulated investment company (RIC) Advisor for U.S. federal income tax purposes, and intend to continue to qualify annually thereafter, as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code).

The Advisor oversees (subject to the oversight of the Board) the management of our operations and is responsible for making investment decisions with respect to our portfolio pursuant to the terms of the Investment Advisory Agreement. Under the Investment Advisory Agreement, we have agreed to pay the Advisor an annual management fee as well as an incentive fee based on our investment performance.

Pursuant to the Service Agreement, the Advisor is responsible for providing, at the expense of the Fund, certain treasury, valuation and portfolio and cash management services to the Fund. Pursuant to the Service Level Agreement, JHIM provides certain financial, accounting and administrative services such as legal, tax, accounting, financial reporting and performance, compliance and service provider oversight services. Pursuant to the Service Agreement, the Advisor shall determine, subject to Board approval, the expenses to be reimbursed by the Fund, including an overhead allocation. The payments under the Service Agreement are not intended to provide a profit to the Advisor. Instead, the Advisor provides the services under the Service Agreement because it also provides advisory services under the Investment Advisory Agreement. The reimbursement shall be calculated and paid monthly in arrears. Similarly, under the Service Level Agreement, the Advisor pays JHIM compensation on an at-cost basis, and JHIM does not earn any profit.

We expect to conduct the continuous private offering of our Common Shares (the Private Offering) in reliance on exemptions from the registration requirements of the Securities Act, including the exemption provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder, Regulation S under the Securities Act and other exemptions from the registration requirements of the Securities Act. We are initially offering one class of our Common Shares – the Class NAV shares – and may offer additional classes of our Common Shares in the future. We and the Advisor may apply for the Multi- Class Exemptive Relief from the SEC that, if granted, would permit us to issue multiple classes of shares of our Common Shares with varying sales loads, contingent deferred sales charges, and/or asset-based service and/or distribution fees, the details for which will be finalized at a later date in our discretion. We have not yet applied for the Multi-Class Exemptive Relief, and there is no assurance that such relief would be granted.

We commenced operations concurrent with the initial closing on the Seed Contribution and, prior to the BDC Election Date, we have conducted our investment activities and operations pursuant to the exclusion from the definition of an “investment company” in Section 3(c)(7) of the 1940 Act. Following the BDC Election Date, we commenced holding monthly closings for the Private Offering, in connection with which we issued Common Shares to investors for immediate cash investment. If there are no purchases for the Private Offering for a particular month, a closing will not be held for that month.

Our investment objectives are to maximize the total return to our shareholders in the form of current income and, to a lesser extent, capital appreciation. The Fund invests primarily in the debt of private middle-market U.S. companies with a focus on directly originated first and second lien loans (including delayed draw term loans and revolving credit facilities) typically created by a club of lenders, as well as related equity investments in companies in which loans have been made by the Fund to middle-market companies. The club of lenders is generally a small group of investment firms.

Investments

Our level of investment activity can and is expected to vary substantially from period to period depending on many factors, including the amount of debt available to middle-market companies, the general economic environment and the competitive environment for the type of investments we make.

As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Under the relevant SEC rules, the term “eligible portfolio company” includes all private companies, companies whose securities are not listed on a national securities exchange, and certain public companies that have listed their securities on a national securities exchange and have a market capitalization of less than $25 million.

28

Revenues

We plan to principally generate revenues in the form of interest income and, to a lesser extent, capital appreciation on the debt investments we hold, as well as dividends and other distributions on the equity or other securities we hold. In addition, we plan to generate revenues in the form of non-recurring commitment, closing, origination, structuring or diligence fees, monitoring fees, fees for providing managerial assistance, consulting fees, prepayment fees and performance-based fees. Our portfolio activity also reflects the proceeds of sales of securities.

Expenses

The Fund bears all costs of its organization and operation, including but not limited to, as applicable, expenses of preparing, printing and mailing all shareholders’ reports, notices, prospectuses, proxy statements and reports to regulatory agencies; expenses relating to the offering and issuance of shares; investment advisory fees payable under the Investment Advisory Agreement; government fees; interest charges; expenses of furnishing to investors their account statements; taxes; brokerage and other expenses connected with the execution and servicing of portfolio securities and securities transactions; fees and expenses of custodians including those for keeping books and accounts, maintaining any line of credit and calculating the NAV of shares; fees and expenses of dividend disbursing agents; legal, accounting, financial, management, tax and auditing fees and expenses of the Fund (including an allocable portion of the cost of the Advisor’s or an affiliate of the Advisor’s employees rendering such services to the Fund); expenses of Trustees’ and investors’ meetings; trade association memberships; fidelity bond and other insurance premiums; any extraordinary expenses; and all other expenses incurred by the Fund or Advisor with administering the Fund’s business. In addition, the Fund will be responsible for other expenses, fees, taxes, penalties and costs associated with the Fund’s investments, including but not limited to filing fees, fees to third party sub-servicers, taxes payable or required to be withheld by or in respect of the Fund or to which the Fund may be subject, any reasonably incurred fees and expenses relating to legal, accounting, bank or other financial intermediaries, third party advisors and consultants, due diligence, research, litigation and restructuring costs and expenses and all other out of pocket expenses of the Advisor and any affiliate to whom it has delegated any of its functions, power, responsibilities or duties. The Fund indirectly bears the cost related to the SPV, including cost, related to borrowings from the JPM Funding Facility, such as interest expense and other fees. Certain fees may be waived or reimbursed by the Advisor.

Pursuant to a Service Agreement, the Advisor is responsible for providing, at the expense of the Fund, certain treasury, valuation and portfolio and cash management services to the Fund. Pursuant to the Service Level Agreement, JHIM provides certain financial, accounting and administrative services such as legal, tax, accounting, financial reporting and performance, compliance and service provider oversight services. Pursuant to the Service Agreement, the Advisor shall determine, subject to Board approval, the expenses to be reimbursed by the Fund, including an overhead allocation. The payments under the Service Agreement are not intended to provide a profit to the Advisor. Instead, the Advisor provides the services under the Service Agreement because it also provides advisory services under the Investment Advisory Agreement. The reimbursement shall be calculated and paid monthly in arrears. Similarly, under the Service Level Agreement, the Advisor pays JHIM compensation on an at-cost basis, and JHIM does not earn any profit.

In addition, we have contracted with SS&C Technologies, Inc. (SS&C) to provide various accounting and administrative services, including, but not limited to, preparing preliminary financial information for review by the Advisor, maintaining accounting and corporate books and records, recording investment and shareholder transactions, preparing and reviewing bank account reconciliations and maintaining dividend reinvestment plan.

The Advisor has agreed to advance all of our organization and offering expenses on our behalf (including legal, accounting, printing, mailing, subscription processing and filing fees and expenses and other offering expenses, including costs associated with technology integration between the Fund’s systems and those of our participating brokers, reasonable bona fide due diligence expenses of participating brokers supported by detailed and itemized invoices, costs in connection with preparing sales materials and other marketing expenses, design and website expenses, fees to attend retail seminars sponsored by participating brokers and costs, expenses and reimbursements for travel (provided that the Fund shall not be required to bear the cost of private airfare in excess of comparable first- class/business rates on a commercial airline, if available), meals, accommodations, entertainment and other similar expenses related to meetings or events with prospective investors, brokers, registered investment advisors or financial or other advisors, but excluding the shareholder servicing and/or distribution fee) through a date determined by the Advisor in its discretion.

From time to time, the Advisor or its affiliates may pay third-party providers of goods or services. We will reimburse the Advisor or such affiliates thereof for any such amounts paid on our behalf. From time to time, the Advisor may defer or waive fees and/or rights to be reimbursed for expenses. All of the foregoing expenses will ultimately be borne by our shareholders.

Portfolio and Investment Activity

As of September 30, 2024, the Fund had investments, excluding cash equivalents, in 44 portfolio companies across 7 sectors and 18 industries. Based on fair value as of September 30, 2024, 135.5% of the Fund’s net assets was invested in debt bearing a floating interest rate, all of which had an interest rate floor denoted in Secured Overnight Financing Rate (SOFR). The weighted average interest rate floor across the Fund’s portfolio was approximately 1.0% as of September 30, 2024. These floors allow the Fund to mitigate (to a degree) any impact of spread widening on the valuation of the Fund’s investments. As of September 30, 2024, the Fund’s estimated weighted average total yield of investments in debt securities was 10.4%. Weighted average yields are based on interest rates as of September 30, 2024.

29

As of December 31, 2023, the Fund had investments, excluding cash equivalents, in 26 portfolio companies across 7 sectors. Based on fair value as of December 31, 2023, 87.9% of the Fund’s net assets was invested in debt bearing a floating interest rate, all of which had an interest rate floor denoted in SOFR. The weighted average interest rate floor across the Fund’s portfolio was approximately 1.0% as of December 31, 2023. These floors allow the Fund to mitigate (to a degree) any impact of spread widening on the valuation of the Fund’s investments. As of December 31, 2023, the Fund’s estimated weighted average total yield of investments in debt securities was 11.4%. Weighted average yields are based on interest rates as of December 31, 2023.

Our portfolio and investment activity for the nine months ended September 30, 2024 is presented below (information presented herein is at amortized cost unless otherwise indicated):

	For the nine months ended September 30, 2024
Investments:
Total investments, beginning of period	$	66,716,527
Purchase of investments		90,536,469
Proceeds from principal repayments and sales of investments		(22,910,425	)
Net purchases and sales of short-term investments		(7,561,689	)
Payment-in-kind interest		—
Amortization of premium/accretion of discount, net		74,233
Net realized gain (loss) on investments		60,970
Total investments, end of period	$	126,916,085
Portfolio companies at beginning of period		26
Number of new portfolio companies funded		19
Number of portfolio companies sold or repaid		(1	)
Portfolio companies at end of period		44
Count of investments		137
Count of industries		18

As of September 30, 2024 and December 31, 2023, our investments, excluding unfunded loan commitments, consisted of the following:

	September 30, 2024							December 31, 2023
	Amortized Cost		Fair Value		% of Investments at Fair Value			Amortized Cost		Fair Value		% of Investments at Fair Value
First-Lien Loans	$	115,079,227	$	116,653,930		90.8	%	$	47,317,980	$	47,912,823		71.2	%
Other Securities		11,836,858		11,836,858		9.2	%		19,398,547		19,398,547		28.8	%
Total Investments	$	126,916,085	$	128,490,788		100.0	%	$	66,716,527	$	67,311,370		100.0	%

30

Portfolio Composition	As of 9-30-24 (% of net assets)			As of 12-31-23 (% of net assets)
Senior loans		135.5			87.9
Short-term investments and other (less unfunded loan commitments)		(35.5	)		12.1

Sector Composition	As of 9-30-24 (% of net assets)			As of 12-31-23 (% of net assets)
Industrials		64.0			48.3
Health care		26.5			12.7
Consumer discretionary		24.9			9.5
Information technology		7.7			3.2
Consumer staples		6.6			4.5
Materials		3.9			6.5
Financials		1.9			3.2
Short-term investments and other (less unfunded loan commitments)		(35.5	)		12.1
		100			100

Industry Composition as of 9-30-24 (% of net assets)
Commercial services and supplies	26.0
Trading companies and distributors	23.5
Health care providers and services	23.2
Professional services	7.7
Hotels, restaurants and leisure	7.4
Consumer staples distribution and retail	6.6
Diversified consumer services	6.5
IT services	4.6
Chemicals	3.9
Air freight and logistics	3.9
Specialty retail	3.9
Leisure products	3.5
Health care equipment and supplies	3.3
Software	3.1
Building products	2.9
Capital markets	1.9
Automobile components	1.9
Textiles, apparel and luxury goods	1.7
Short-term investments and other (less unfunded loan commitments)	(35.5	)

Percentages include unfunded loan commitments.

As of September 30, 2024 and December 31, 2023, 100% of investments held were based in the United States.

31

Top 10 Issuers as of 9-30-24 (% of net assets)
Star Logistics & Hospitality Services LLC	4.0
Renovation Systems LLC	4.0
Security Services Acquisition Sub Corp.	4.0
OIS Management Services LLC	4.0
Chemtron Supply LLC	3.9
WeLocalize, Inc.	3.9
American Combustion Industries, Inc.	3.9
Hill Country Dairies, Inc.	3.9
PNB Holdings III LLC	3.9
RPC TopCo, Inc.	3.9
Total	39.4

Cash and cash equivalents are not included.

Percentages include unfunded loan commitments.

Top 10 Issuers as of 12-31-23 (% of net assets)
Pak Quality Foods Acquisition LLC	4.5
BLP Buyer, Inc.	4.4
BCTS Parent LLC	4.1
Beary Landscaping LLC	4.0
OIS Management Services LLC	3.3
PVI Holdings, Inc.	3.3
Paint Intermediate III LLC	3.3
Gannet Fleming, Inc.	3.3
Capital Construction LLC	3.3
Chemtron Supply LLC	3.3
Total	36.8

Cash and cash equivalents are not included.

Percentages include unfunded loan commitments.

32

Results of Operations

Our operating results for the three and nine months ended September 30, 2024 were as follows:

	For the three months ended		For the nine months ended
	September 30, 2024		September 30, 2024
Increase (decrease) in net assets from operations	$	2,621,838	$	7,342,623

Net increase (decrease) in net assets from operations can vary from period to period as a result of various factors, including acquisitions, the level of new investment commitments, the recognition of realized gains and losses and changes in unrealized appreciation and depreciation in the investment portfolio.

Our investment income for the three and nine months ended September 30, 2024 was as follows:

	For the three months ended		For the nine months ended
	September 30, 2024		September 30, 2024
Investment income
From non-controlled/non-affiliated investments: Interest	$	3,120,423	$	7,482,470
Dividends		105,736		888,917
Other income		42,894		85,499
Total investment income	$	3,269,053	$	8,456,886

For the three and nine months ended September 30, 2024, total investment income was driven by the Fund’s deployment of capital and invested balance of investments. The size of the Fund’s investment portfolio at fair value was approximately $128.5 million as of September 30, 2024 and, as of such date, all of the Fund’s debt investments were income-producing.

Interest income on the Fund’s debt investments is dependent on the composition and credit quality of the portfolio. Generally, the Fund expects the portfolio to generate predictable quarterly interest income based on the terms stated in each loan’s credit agreement. As of September 30, 2024, all of the Fund’s debt investments were performing and current on their interest payments.

Our expenses for the three and nine months ended September 30, 2024 were as follows:

	For the three months ended			For the nine months ended
	September 30, 2024			September 30, 2024
Expenses
Management fee	$	359,982		$	1,015,120
Accounting and legal services fees		16,659			29,747
Trustee fees		19,324			63,253
Professional fees		(133,744	)		470,566
Custody and accounting fees		62,771			169,323
Transfer Agent		2,815			13,367
Printing and postage		—			15,215
Organization cost		—			24,253
Offering cost		6,751			208,618
Interest and credit facility expenses		464,148			940,743
Other expenses		28,967			56,208
Total expenses		827,673			3,006,413
Less expense reductions		68,454			(851,320	)
Net expenses	$	896,127		$	2,155,093

33

Interest and credit facility expenses include interest expense, amortized deferred financing cost, unused commitment fee and utilization fee related to the JPM Funding Facility. During the three months ended September 30, 2024, legal fees related to establishing the JPM Funding Facility were capitalized and are being amortized over the life of the facility, and therefore, professional fees have been adjusted accordingly.

Other expenses include insurance, valuation, subscriptions and other costs.

Organization and offering costs include expenses incurred in the Fund’s initial formation and the Fund’s offering of Common Shares.

Expense reductions include contractual management fee waivers.

Income Taxes, Including Excise Taxes

The Fund has elected and intends to continue to qualify as a RIC under Subchapter M of the Code. As a RIC, the Fund generally will not have to pay corporate-level U.S. federal income taxes on any income and net capital gain that it distributes to shareholders as dividends. To qualify as a RIC, the Fund must, among other things, meet certain source-of-income and asset diversification requirements. In addition, in order to be eligible for pass-through tax treatment as a RIC, the Fund must distribute to the Fund’s shareholders, for each taxable year, at least the sum of 90% of the Fund’s “investment company taxable income,” which is generally net ordinary income plus the excess of realized net short term capital gains over realized net long-term capital losses and 90% of its net exempt interest income, if any, or the “Annual Distribution Requirement.”

For the three and nine months ended September 30, 2024, the Fund did not incur any excise tax.

Financial Condition, Liquidity and Capital Resources

We generate cash primarily from the net proceeds from the Private Offering and from cash flows from interest and fees earned from our investments and principal repayments and proceeds from sales of our investments. We may also fund a portion of our investments through borrowings from banks and issuances of senior securities, including before we have fully invested the proceeds of the Private Offering. Our primary use of cash will be investments in portfolio companies, payments of our expenses, payment of cash distributions to our shareholders and repurchases of our Common Shares under our share repurchase program.

Equity

For the nine months ended September 30, 2024, we held three closings of our continuous Private Offering. As a result, the total Class NAV shares issued, and proceeds received related to such closings were as follows:

Shares issued date	Class NAV shares issued		Proceeds Received
January 2, 2024		723,237	$	15,000,000
February 1, 2024		718,284	$	15,000,000
March 1, 2024		714,078	$	15,000,000

Credit Facilities

We utilize leverage to finance our investments. The amount of leverage that we employ will be subject to the restrictions of the 1940 Act and the supervision of our Board. At the time of any proposed borrowing, the amount of leverage we employ will also depend on our Advisor’s assessment of market and other factors.

We have established one or more credit facilities and may enter into other financing arrangements to facilitate investments and the timely payment of our expenses. It is anticipated that any such credit facilities will bear interest at floating rates at to-be-determined spreads over a specified reference rate. We cannot assure shareholders that we will be able to enter into a credit facility on favorable terms or at all. In connection with a credit facility or other borrowings, lenders may require us to pledge assets, commitments and/or drawdowns (and the ability to enforce the payment thereof) and may ask to comply with positive or negative covenants that could have an effect on our operations.

34

JPM Funding Facility

On March 26, 2024, Manulife Private Credit Fund SPV, LLC, a wholly owned consolidated subsidiary of the Fund, entered into a Loan and Security Agreement (the JPM Funding Facility), as borrower (the Borrower), with the Fund, as the parent and portfolio manager, The Bank of New York Mellon Trust Company, National Association, as collateral agent, collateral administrator and securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provides a secured credit facility of up to $150 million with a reinvestment period ending March 26, 2027 and a final maturity date of March 26, 2029. The JPM Funding Facility also provides for a feature that allows the Borrower, subject to certain conditions, to increase the overall size of the JPM Funding Facility to a maximum of $500 million. In addition, on March 26, 2024, the Fund, as seller, and the Borrower, as purchaser, entered into a Sale and Contribution Agreement, pursuant to which Borrower will either purchase certain corporate loans or receive contributions of cash or such corporate loans (collectively, the Loans), from time to time, originated by the Fund or its affiliates.

The obligations of the Borrower under the JPM Funding Facility are secured by substantially all assets held by the Borrower, including the Loans. Borrowings under the JPM Funding Facility will bear interest at Term SOFR or an alternate base rate, in each case plus an applicable margin equal to 2.70%, subject to increases for default rate interest from time to time pursuant to the terms of the JPM Funding Facility. In addition, the Borrower will pay, among other fees, an upfront fee, an administrative agency fee and a commitment fee on the undrawn balance of 0.55% per annum (or, during the March 26, 2024 to March 27, 2025 ramp-up period, 0.30% per annum) on the average daily unused facility amount.

Under the JPM Funding Facility, the Fund and the Borrower, as applicable, have made customary representations and warranties regarding their businesses, among other things, and are required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities. The JPM Funding Facility includes usual and customary events of default for such facilities of this nature. Proceeds from the JPM Funding Facility must be used for the purposes permitted in the JPM Funding Facility, including purchasing of loans or other portfolio investments.

As of September 30, 2024, the Fund had outstanding borrowings of $15,000,000 at an average interest rate of 7.60%, which is reflected in the Credit facility payable on the Consolidated Statements of Assets and Liabilities. During the three and nine months ended September 30, 2024, the average daily outstanding borrowings for the JPM Funding Facility amounted to $5,197,183 and $4,386,905 and the weighted average interest rate was 7.78% and 7.89%, respectively.

JH Funding Revolving Promissory Note Agreement

On July 17, 2023, we entered into revolving promissory note agreement with JH Funding. The aggregate outstanding borrowings under the agreement with JH Funding for the Fund would not exceed $30 million. There were no upfront fees or commitment fees paid by the Fund in connection with the agreement. As of September 30, 2024 and December 31, 2023, the Fund did not have any borrowings outstanding under the agreement with JH Funding. The agreement terminated upon the effective date of the JPM Funding Facility on March 26, 2024.

For further details, see “Note 5 – Borrowings” under “Item 1. Consolidated Financial Statements (Unaudited)” in the accompanying unaudited consolidated financial statements.

Contractual Obligations, Off-Balance Sheet Arrangements and Other Liquidity Considerations

We have entered into certain contracts under which we may have material future commitments. We have entered into each of the Investment Advisory Agreement and the Service Agreement with the Advisor to provide us with investment advisory services and administrative services. Payments for investment advisory services under the Investment Advisory Agreement and reimbursements made under the Service Agreement are described in “Part I Item 1. Business – Management Agreements” of our December 31, 2023 Form 10-K. The Advisor is responsible for payments under the Service Level Agreement.

If any of our contractual obligations are terminated, our costs may increase under any new agreements that we enter into as replacements. We would also likely incur expenses in locating alternative parties to provide the services we expect to receive under our Investment Advisory Agreement and our Service Agreement, and the Service Level Agreement between the Advisor and JHIM.

We may become a party to financial instruments with off-balance sheet risk in the normal course of our business to meet the financial needs of our portfolio companies. These instruments may include commitments to extend credit and involve, to varying degrees, elements of liquidity and credit risk in excess of the amount recognized in the balance sheet.

35

As of September 30, 2024 and December 31, 2023, the Fund had the following unfunded commitments outstanding:

	September 30, 2024				December 31, 2023
Unfunded term loan	Principal on delayed draw term loan		Principal on revolver		Principal on delayed draw term loan		Principal on revolver
4M Capital, Ltd.		—	$	528,000		—		—
Air Buyer, Inc.	$	750,000		340,909		—		—
American Combustion Industries, Inc.		1,005,670		359,168		—		—
Bandon Fitness, Inc.		1,818,352		114,804	$	191,049	$	45,462
BCTS Parent LLC		824,176		283,587		974,832		283,587
Beary Landscaping LLC		422,535		405,634		422,535		422,535
BLP Buyer, Inc.		—		268,548		290,323		268,548
Capital Construction LLC		243,639		508,039		—		161,862
Chemtron Supply LLC		2,333,630		362,979		725,959		362,979
CPC Lakeshirts Acquisition LLC		—		316,689		258,419		329,357
Diverzify Intermediate LLC		1,371,429		—		—		—
Gannet Fleming, Inc.		—		—		—		297,877
Health Management Associates, Inc.		155,005		105,403		210,806		124,004
Hill Country Dairies, Inc.		1,088,710		689,516		—		—
In Vitro Sciences LLC		7,111		177,778		—		—
Jetson Buyer, Inc.		—		399,290		—		—
Krayden Holdings, Inc.		1,393,071		574,269		517,388		272,309
Leap Service Partners LLC		905,882		382,353		—		—
Library Associates LLC		—		24,139		—		72,418
Lockmasters Security Intermediate, Inc.		878,274		205,895		—		—
M&D Midco, Inc.		352,239		125,337		233,629		225,607
Midwest Eye Services LLC		—		142,385		—		142,385
OIS Management Services LLC		2,053,991		167,626		—		167,626
Paint Intermediate III LLC		—		81,193		—		216,516
Pak Quality Foods Acquisition LLC		537,313		313,433		537,313		268,657
PNB Holdings III LLC		1,227,273		572,727		—		—
Refocus Management Services LLC		747,368		210,526		—		—
Renovation Systems LLC		1,096,996		68,894		—		—
RPC TopCo, Inc.		—		545,455		—		—
Security Services Acquisition Sub Corp.		—		—		1,245,556		—
Star Logistics & Hospitality Services LLC		1,607,143		482,143		—		—
Steward Partners Global Advisory LLC		406,790		311,716		480,043		311,716
SurfacePrep Buyer LLC		547,945		479,452		—		—
The Smilist DSO LLC		280,069		140,351		—		—
VPD Management, Inc.		3,028,571		228,571		—		—
WeLocalize, Inc.		—		224,852		—		—
WWEC Holdings III Corp.		824,818		434,020		—		220,719
XpressMyself.com LLC		—		233,050		—		233,050
Total	$	25,908,000	$	10,808,731	$	6,087,852	$	4,427,214

36

Distributions and Dividend Reinvestment Plan

Distributions

The Fund intends to make quarterly distributions of net investment income. Any distributions we make will be at the discretion of our Board, who will consider, among other things, our earnings, cash flow, capital needs and general financial condition, as well as our desire to comply with the RIC requirements, which generally require us to make aggregate annual distributions to our shareholders of at least 90% of our net investment income. As a result, distributions to shareholders cannot be assured, and the amount of each quarterly distribution is likely to vary. Distributions to shareholders from net investment income and net realized gains, if any, are recorded on the ex-date. The Fund generally declares and pays dividends at least quarterly. Capital gain distributions, if any, are typically distributed annually.

The following table summarizes the distributions declared on our common shares for the three and nine months ended September 30, 2024

Date Declared	Record Date	Payment Date	Dividend Per Share
March 27, 2024	March 26, 2024	April 19, 2024	$	0.20347
June 27, 2024	June 26, 2024	July 22, 2024	$	0.40293
September 27, 2024	September 26, 2024	October 21, 2024	$	0.43716

Dividend Reinvestment Plan

Pursuant to the Dividend Reinvestment Plan (DRP) established by the Fund, each shareholder will automatically be a participant under the DRP and have all income distributions, whether dividend distributions or capital gains distributions, automatically reinvested in additional Common Shares. Election not to participate in the DRP and to receive all income distributions, whether dividend distributions or capital gains distributions, in cash may be made by notice to a shareholder’s intermediary (who should be directed to inform the Fund). A shareholder is free to change this election at any time. If, however, a shareholder elects to change its election within 95 days prior to a distribution, the request will be effective only with respect to distributions after the 95-day period. A shareholder whose Common Shares are registered in the name of a nominee (such as an intermediary) must contact the nominee regarding its status under the DRP, including whether such nominee will participate on such shareholder’s behalf as such nominee will be required to make any such election.

Generally, for U.S. federal income tax purposes, shareholders receiving Common Shares under the DRP will be treated as having received a distribution equal to amount payable to them in cash as a distribution had the shareholder not participated in the DRP.

Common Shares will be issued pursuant to the DRP at their NAV determined on the next valuation date following the ex-dividend date (the last date of a dividend period on which an investor can purchase Common Shares and still be entitled to receive the dividend). There is no sales load or other charge for reinvestment. A request for change of participation/non-participation status in the DRP must be received by the Fund within the above timeframe to be effective for that dividend or capital gain distribution. The Fund may terminate the DRP at any time upon written notice to the participants in the DRP. The Fund may amend the DRP at any time upon 30 days’ written notice to the participants. Any expenses of the DRP will be borne by the Fund.

As of September 30, 2024 and December 31, 2023, no Common Shares were issued pursuant to the DRP.

Related Party Transactions

We have entered into a number of business relationships with affiliated or related parties, including the following (which are defined in the notes to the accompanying consolidated financial statements if not defined herein):

• the Investment Advisory Agreement;

• the Service Agreement;

• the Placement Agency Agreement;

• the Expense Limitation and Reimbursement Agreement; and

• the Sale and Contribution Agreement

See “Note 4 – Agreements and transactions with related parties” and “Note 5 – Borrowings” under “Item 1. Consolidated Financial Statements (Unaudited)” in the accompanying unaudited consolidated financial statements.

37

Critical Accounting Policies and Use of Estimates

Our consolidated financial statements are prepared in conformity with US GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Management utilizes available information, which includes our history, industry standards and the current economic environment, among other factors, in forming the estimates and judgments, giving due consideration to materiality. Actual results may differ from these estimates. In addition, other companies may utilize different estimates, which may impact the comparability of our results of operations to those of companies in similar businesses. Understanding our accounting policies and the extent to which we use management judgment and estimates in applying these policies is integral to understanding our financial statements. We describe our most significant accounting policies in the notes to our unaudited consolidated financial statements.

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

We are subject to financial market risks, including changes in interest rates. A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to the variable rate investments we may hold and to declines in the value of any fixed rate investments we may hold. A rise in interest rates would also be expected to lead to higher cost on our floating rate borrowings.

We expect that our long-term investments will be financed primarily with equity and debt. If deemed prudent, we may use interest rate risk management techniques in an effort to minimize our exposure to interest rate fluctuations. These techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.

We plan to invest primarily in illiquid debt securities of private companies. Most of our investments will not have a readily available market price, and we will value these investments at fair value as determined in good faith pursuant to procedures adopted by the Advisor and overseen by the Board in accordance with the Advisor’s valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. See “Part I Item 1. Business – Determination of Net Asset Value.” of our December 31, 2023 Form 10-K.

From time to time, we may make investments that are denominated in a foreign currency that are subject to the effects of exchange rate movements between the foreign currency of each such investment and the U.S. dollar, which may affect future fair values and cash flows, as well as amounts translated into U.S. dollars for inclusion in our consolidated financial statements. We may use derivative instruments from time to time, including foreign currency forward contracts and cross currency swaps, to manage the impact of fluctuations in foreign currency exchange rates. In addition, we may have the ability to borrow in foreign currencies under any credit facilities or enter into other financing arrangements, which provides a natural hedge with regard to changes in exchange rates between the foreign currencies and U.S. dollar and reduces our exposure to foreign exchange rate differences. We expect to typically be a net receiver of these foreign currencies as related for our international investment positions, and, as a result, our investments denominated in foreign currencies, to the extent not hedged, are expected to benefit from a weaker U.S. dollar and are adversely affected by a stronger U.S. dollar. See “Part I Item 1. Business – Determination of Net Asset Value.” of our December 31, 2023 Form 10-K.

As of September 30, 2024, approximately $117.8 million (principal amount) of our debt portfolio investments (funded positions) bore interest at variable rates, which are generally SOFR-based (or based on an equivalent applicable currency rate), and many of which are subject to certain floors.

Based on our September 30, 2024 Consolidated Statements of Assets and Liabilities, the following table shows the annual impact on net income of hypothetical base rate changes in interest rates on our debt investments and borrowings (considering interest rate floors for variable rate instruments) assuming no changes in our investment and borrowing structure:

	Interest income			Interest expense			Net income
Up 300 basis points	$	3,534,837		$	(450,000	)	$	3,084,837
Up 200 basis points	$	2,356,558		$	(300,000	)	$	2,056,558
Up 100 basis points	$	1,178,279		$	(150,000	)	$	1,028,279
Down 100 basis points	$	(1,178,279	)	$	150,000		$	(1,028,279	)

38

ITEM 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Based upon their evaluation of the Fund’s disclosure controls and procedures as of September 30, 2024 (the end of the period covered by this report), the Fund’s principal executive officer and principal financial officer have concluded that those disclosure controls and procedures were effective as of September 30, 2024 and provided reasonable assurance that the material information required to be disclosed by the Fund on this report is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

ITEM 1. Legal Proceedings.

There are no legal proceedings to which the Fund or the Advisor is a party that are likely to have a material adverse effect on the Fund or the ability of the Advisor to perform its services under the Investment Advisory Agreement with the Fund, nor, to our knowledge, is any material legal proceeding threatened against us or the Advisor.

ITEM 1A. Risk Factors

Investing in our Common Shares involves a number of significant risks. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in “Part I Item 1A. Risk Factors” our December 31, 2023 Form 10-K, which could materially affect the Fund’s business, financial condition and/or operating results. The risks described in our December 31, 2023 Form 10-K are not the only risks we face. Additional risks and uncertainties not presently known to us or not presently deemed material by us may also impair our operations and performance. During the three months ended September 30, 2024, there have been no material changes from the risk factors set forth in our December 31, 2023 Form 10-K.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

The Fund offers and sells its Common Shares in a Private Offering under the exemption provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder. During the period covered by this Quarterly Report on Form 10-Q, the Fund did not sell any unregistered securities.

ITEM 3. Defaults Upon Senior Securities

None

ITEM 4. Mine Safety Disclosures.

Not applicable.

39

ITEM 5. Other Information.

(a) None.

(b) None.

(c) For the period covered by this Quarterly Report on Form 10-Q, no trustee or officer of the Fund has entered into any (i) contract, instruction or written plan for the purchase or sale of securities of the Fund intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934 or (ii) any non-Rule 10b5-1 trading arrangement.

4

0

ITEM 6. Exhibits.

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

3.1	Certificate of Trust(1)
3.2	Certificate of Amendment to Certificate of Trust(1)
3.3	Amended and Restated Agreement and Declaration of Trust(2)
3.4	Bylaws(1)
31.1	Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2	Certification of Principal Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.*
32.2	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.*
101.INS*	Inline XBRL Instance Document
101.SCH*	Inline XBRL Taxonomy Extension Schema Document
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Filed herewith

(1) Incorporated by reference to the Fund’s Form 10-12G filed by the Fund on August 4, 2023 (File No. 000-56578).

(2) Incorporated by reference to Amendment No. 1 to the Fund’s Form 10-12G filed by the Fund on September 19, 2023 (File No. 000-56578).

41

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Manulife Private Credit Fund
Date: November 12, 2024	By:	/s/ Ian Roke
		Name: Ian Roke
		Title: Chief Executive Officer (Principal Executive Officer)
Date: November 12, 2024	By:	/s/ Heidi Knapp
		Name: Heidi Knapp
		Title: Chief Financial Officer (Principal Financial Officer)

42